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THE SPEED OF INTRAVENOUS COCAINE DELIVERY ALTERS ITS EFFECT 
ON THE BRAIN AND DRUG-TAKING BEHAVIOR: IMPLICATIONS FOR 
ADDICTION LIABILITY 
by 
Ken Taro Wakabayashi 
Chair: Terry E. Robinson 
Cocaine addiction in humans is a severe health and social problem.  Therefore, 
understanding how casual use transforms into addiction is critical.  One of the many 
factors that can facilitate addiction is how rapidly drugs like cocaine enter the brain.   
Faster rates of cocaine delivery have a greater neurobiological impact on brain 
reward systems, producing sensitization.  This may facilitate the transition to addiction by 
changing systems in the brain underlying reward. Yet most studies in the rat have shown 
few effects of rate of delivery on drug-taking behavior. Recently, paradigms have been 
developed where rats given extended access to take cocaine develop addiction-like 
behaviors.  If the rate of drug delivery influences its addictive liability, it can be predicted 
that faster rates of cocaine delivery will be associated with a greater neurobiological 
impact and addiction-like behavior. 
The studies in this dissertation tested this prediction. In the first study, fast rates (5 
sec) of infusion induced more Fos expression, a marker for neurobiological impact, than 
slower rates (25 – 100 sec). This effect was equally evident in the patch and matrix 
subcompartments of the striatum, a brain reward sub-system implicated in addiction, 
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suggesting that fast rates of infusion had a widespread impact on this structure. In the 
second study, faster rates (5 – 45 sec) of cocaine infusion facilitated an escalation in 
overall drug intake in contrast to slower rates (90 sec) when rats were given extended, but 
not limited, access to cocaine. In the third study, fast (5 sec) rates of cocaine infusion 
during extended access self- administration was associated with a persistence to reinstate 
drug-seeking behavior in response to a drug induced priming injection 45 days after their 
last self-administration session. This behavior in the 5 sec group was also associated with 
more persistent neuroadaptations in the brain. 
Thus, faster rates of cocaine infusion have a greater and more persistent impact on 
brain reward systems, and facilitate the development of behaviors that resemble 
addiction. This may be one reason why routes of administration that result in the rapid 







Given that addiction is such a widespread and persistence public health problem, 
it is important to understand the mechanisms responsible for the transition from casual 
drug use to addiction. However, this is still poorly understood. Many factors such as 
those related to the individual and the environment contribute to addiction liability, but 
here I will focus on factors intrinsic to the drug, drug formulation and/or route of 
administration. In particular, the rate at which one drug, cocaine, reaches the brain will be 
discussed in detail as the rate at which cocaine is delivered influences both its behavioral 
and neurobiological effects. This may be why certain forms of cocaine that result in faster 
absorption into the brain are more addicting than forms resulting in slower uptake. 
Although there is some epidemiological and clinical evidence supporting this hypothesis 
in humans, very little basic research has been conducted on exactly how the rate of 
cocaine delivery influences the behavioral and neurobiological actions of cocaine. 
Recently, animal models of drug-taking that can produce addiction-like symptoms have 
been developed. Using one of these models, experiments in this dissertation will attempt 
to clarify how the rate of cocaine delivery influences behavioral and neurobiological 
processes that may contribute to addiction. 
The goal of this Introduction is to provide sufficient background for 
understanding the scope and intent of these experiments. Thus, the Introduction will 
begin with a review of addiction, cocaine and its properties as a drug of abuse, including 
its acute and chronic actions in the brain and its impact on behavior. I will examine the 
current evidence that the rate of cocaine delivery influences its neurobiological and 
behavioral effects. I will then discuss the use and implications of changes in neuronal 
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gene expression as a method to measure the impact of cocaine on the brain. Finally I will 
introduce self-administration procedures in rats that produce symptoms of addiction 
similar to those in humans, the use of which may further expand our understanding of 
how rate of infusion influences cocaine's addictive potential. 
What is addiction? 
Drug addiction in humans is often defined as a pattern of compulsive drug-taking 
behavior (Robinson and Berridge, 1993; American Psychiatric, 2000). Although the 
addiction liability of a compound has often been determined in animals by testing its 
reinforcing effects – that is, whether or not the compound is reliably self-administered 
(Johanson and Balster, 1978; Johanson, 1984), taking drugs alone is not addiction. 
Human addiction refers to a complex array of symptoms in addition to compulsive use 
(Gawin and Kleber, 1988; Gawin and Ellinwood, 1989; Robinson and Berridge, 1993; 
American Psychiatric, 2000; Deroche-Gamonet et al., 2004; Robinson, 2004). Some of 
these hallmark symptoms of addiction include a marked increase in drug intake (Ahmed 
and Koob, 1998), the development a much greater ‗wanting‘ or craving of drug (Hyman, 
2001; Preston et al., 2009) than non-addict subjects (Walsh et al., 2009), so much so that 
the motivation for drug becomes pathological (Paterson and Markou, 2003; Deroche-
Gamonet et al., 2004; Belin et al., 2008; Walsh et al., 2009) even when drug is not 
available (Deroche-Gamonet et al., 2004; Robinson, 2004). Other symptoms of addiction 
include continued drug seeking or taking in the face of adverse consequences (Deroche-
Gamonet et al., 2004; Vanderschuren and Everitt, 2004; Pelloux et al., 2007; Belin et al., 
2008), and a persistent vulnerability towards relapse even after periods of prolonged 
abstinence (O'Brien, 1997; Deroche-Gamonet et al., 2004; Knackstedt and Kalivas, 2007; 
Belin et al., 2008; Walsh et al., 2009). Thus only when repeated drug self-administration 
gives rise to a constellation of these and other symptoms is a subject considered 
―addicted‖ (Deroche-Gamonet et al., 2004; Robinson, 2004; Vanderschuren and Everitt, 
2004; Belin et al., 2008).  
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Factors that can influence addiction liability of cocaine 
Not everyone who initiates drug use transitions to addiction (Robinson and 
Berridge, 1993). In fact, many factors contribute towards the addiction liability of drugs 
such as cocaine in humans. A few of the factors mediating addiction liability are stress 
(Bell, 1971; Briand and Blendy, 2009), genetic differences (Enoch and Goldman, 1999), 
gender (Becker, 2009), age (Hser et al., 2008), and environmental influences (Robins et 
al., 1975). In addition to these factors, pharmacokinetic factors intrinsic to the drug itself, 
the drug formulation, and/or route of administration also contribute towards addiction 
liability. Thus, drugs or drug formulations that reach the brain rapidly are thought to have 
the greatest potential to produce addiction. This will be the main focus of this 
dissertation. 
A brief synopsis of the impact of formulation and route of administration 
on the history of cocaine addiction 
One drug that differs in its addictive liability depending on its formulation and 
route of administration into the body is the naturally occurring alkaloid cocaine.  In its 
native form, cocaine is extracted from the coca plant Erythroxylon coca (Gay et al., 
1975), a plant that has been cultivated in South America from at least the 6
th
 century 
(Carroll, 1977; Petersen, 1977). In this form, cocaine is self-administered by humans by 
chewing the coca leaf along with an alkali and binder (Gay et al., 1975). In this form, the 
amount of cocaine absorbed is very low (Gay et al., 1975), and the rate of absorption 
through the oral mucous membrane is very slow (Fischman, 1984). When taken this way, 
there is little evidence for toxic effects or coca leaf addiction (Carroll, 1977; Jones, 
1984). Although the euphorigenic properties of the coca plant have been documented as 
early as 1596 by the Spanish (Petersen, 1977), the use of cocaine became more 
widespread after it was chemically isolated and purified in the 1860‘s by Albert Niemann 
and others (Niemann, 1860; Petersen, 1977). At the time, the availability of more purified 
and concentrated forms of cocaine that could be administered more rapidly into the body 
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such as by insufflation led to increasing reports of problems, including addiction and fatal 
overdose (Gay et al., 1975; Petersen, 1977). However, despite subsequent regulation 
(Gay et al., 1975; Gawin and Ellinwood, 1989), debate over cocaine's addictive liability 
persisted into the early 1980's (Gawin and Kleber, 1988). Part of this skepticism was due 
to the unique clinical symptoms of cocaine abstinence, which in contrast to opiates and 
alcohol, lacked physiological withdrawal symptoms (Gawin and Kleber, 1988). In 
addition, only some people developed severe symptoms of addiction (Petersen, 1977). 
Although many factors influence the transition to addiction, one possible explanation for 
this trend may have been that in the late 1970s and early 1980s the majority of cocaine in 
the United States was taken intranasally (―snorting‖), a moderate rate of administration 
resulting in relatively slow delivery of drug to the brain (Hatsukami and Fischman, 
1996).   
However, during the same time period, a few users injected cocaine intravenously 
(i.v.) or converted the water soluble form through an involved and dangerous ―gourmet‖ 
process into a smokable base form (Hatsukami and Fischman, 1996). Smoking free base 
or i.v. injection results in cocaine being delivered more rapidly to the brain (Jones, 1990), 
and people using these very fast routes of administration began reporting greater 
euphorigenic effects: smoking freebase cocaine was described at that time as the 
―ultimate high‖ or the ―greatest thing since sex‖ (Siegel, 1984). Reports by the beginning 
of the 1980s began documenting greater toxicity and escalating patterns of use associated 
with intravenous and smoking free-base cocaine (Siegel, 1984), relative to that seen with 
―snorting‖ cocaine hydrochloride. 
Cocaine use underwent a demographic shift in the United States and other parts of 
the world during the mid-1980s when reports of a more easily producible freebase form 
of cocaine, ―crack‖, first appeared in the Bahamas in 1983 (Jekel et al., 1986).  In 
addition to differences in ethnicity and socioeconomic status, crack cocaine evolved its 
own distinct distribution and use patterns from cocaine hydrochloride. Although crack 
cocaine was sold at the retail level in a number of ways, studies interviewing individual 
users reported that the ―crack house‖ was the method most often used to procure crack 
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cocaine (Mieczkowski, 1990). Although these crack houses all provided a milieu where 
crack cocaine could be bought and consumed, Gerter (1994) proposed a spectrum of 
crack house types, ranging from well kept semiprivate ―party houses‖ catering to working 
class clients intent on the pleasure-seeking and social aspects of drug, to so called 
―bandominiums‖ (i.e. abandoned condominium) where poverty stricken addicts whose 
desire for drug was so strong that they could tolerate drug-taking in an extremely 
dangerous environment surrounded by aversive and practically unlivable conditions 
(Geter, 1994). Additionally, many crack houses provided a permanent and fixed locale 
where addicts could binge on crack cocaine. For example, Mieczowski (1990) reported 
that ―customers‖ of these crack houses would ―meet, smoke, exhaust their funds, 
conspire, leave, commit a property crime, return with merchandise, exchange it for crack, 
and the begin the whole process over again.‖   
Initially, the rapid increase in crack cocaine use, especially by ethnic minorities, 
was largely attributed to its perceived lower market price and greater availability (Jekel et 
al., 1986; Hatsukami and Fischman, 1996). However, others such as Caulkins (1997) 
found no differences in price per unit between cocaine hydrochloride and crack cocaine, 
suggesting that other factors were responsible for its increasingly widespread use (Karch, 
1999). Specifically, the ability of ―crack‖ cocaine to be delivered to the brain more 
rapidly was proposed to be a major contributing factor to its increased abuse liability 
(Jones, 1990; Hatsukami and Fischman, 1996; Karch, 1999). 
Although much of the data on increased addictive liability of crack cocaine in 
humans is anecdotal, several studies have supported this hypothesis. In one survey of 
cocaine addicts undergoing inpatient treatment for cocaine addiction, Gorelick (1992) 
found that cocaine smokers progressed more quickly from initial use to other stages of 
cocaine use than users whose first use was through insufflation. For example, the time 
between initial and regular use of the drug was significantly shorter in patients who 
initiated their use by smoking. In addition, smokers comparatively experienced their first 
cocaine-related intrapersonal conflict sooner than those who began by snorting cocaine. 
Epidemiological studies surveying a larger number of subjects have found that those who 
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initiate their cocaine use through smoking crack cocaine are more likely to develop 
clinical symptoms of addiction than users who initiate their use the intranasal route (Chen 
and Anthony, 2004). A more recent study reports that subjects who initiate their cocaine 
use either by crack or i.v. injection have a higher relative risk of developing symptoms of 
dependence within two years of initiating cocaine use (O'Brien and Anthony, 2005). In a 
related vein, others have found that many cocaine users transition from an initially slower 
intranasal route of administration to a more rapid route of infusion such as smoking or 
intravenous injection as their addiction progresses (Gorelick, 1992; Dunn and Laranjeira, 
1999).  
Today, the use of cocaine hydrochloride and crack cocaine is acknowledged to be 
a persistent contemporary public health problem. For example, in 2008 the prevalence of 
cocaine use (including crack) in the previous month amongst people 12 years or older in 
the United States was projected to be 1.9 million people (National Survey on Drug Use 
and Health). Clearly, there is considerable interest in understanding factors that influence 
cocaine's addictive liability, such as how rapidly it reaches the brain. 
The acute behavioral and physiological effects of cocaine 
Euphoric and reinforcing effects 
In humans, cocaine has potent euphorigenic effects that are well documented 
historically (e.g. Freud 1884) and clinically depending on the rate and dose of drug 
(Resnick et al., 1977; Fischman, 1984; Volkow et al., 2000; Abreu et al., 2001; Nelson et 
al., 2006). Cocaine is highly reinforcing in animals based on a number of different tests. 
Importantly, animals can be easily trained to self-administer cocaine over a number of 
different operant rules that govern the relationship between the required behavior and the 
delivery of cocaine (Deneau and Seevers, 1964; Pickens and Thompson, 1968; Wilson et 
al., 1971; Johanson, 1984). For example, animals will administer cocaine over Fixed 
Ratio (FR) schedules, where a certain number of responses are required before cocaine is 
delivered (e.g. Wilson et al., 1971 ; Downs & Woods 1974), Fixed Interval (FI) schedules 
where reward is available at certain time intervals (e.g. Balster and Schuster 1973, 
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Goldberg and Kelleher 1976), and progressive ratio schedules (PR), were each successive 
drug delivery requires an increasingly larger number of behavioral responses (Griffiths et 
al., 1975). Cocaine is also reinforcing in a conditioned place preference paradigm (e.g. 
Mucha et al., 1982; Morency and Beninger 1986). In this paradigm, animals are 
administered drug in test chambers with distinct spatial and environmental cues. In later 
tests, the environment where the drug was experienced becomes preferred over one that 
was not. 
Peripheral effects 
Acute cocaine administration has many physiological effects in the periphery that 
are dose dependent. In rodents and in primates, cocaine produces pupil dilation as well 
as, increases in heart rate and respiration, blood pressure, and body temperature. At 
higher doses cocaine is also a convulsant, and may induce respiratory depression and 
cardiovascular collapse. A combination of these effects are responsible for lethal 
overdose (Woods, 1977). 
Psychomotor activation 
Given acutely, cocaine induces a range of behaviors termed ―psychomotor 
activation,‖ a term of German etymology meaning ―movement induced by psychic or 
mental action‖ (Wise and Bozarth, 1987). In animals, acute cocaine results in an increase 
in locomotion at low doses, and repetitive and stereotyped behaviors at higher doses such 
as grooming a portion of the body (Woods, 1977); this property is shared by 
phenylethylamine stimulants like amphetamine, and many other drugs of abuse (Wise 
and Bozarth, 1987).  
The rate of drug delivery can influence cocaine’s subjective effects 
Why is crack cocaine potentially more addictive than cocaine hydrochloride? 
Although it is the same drug, crack cocaine is delivered to the brain faster when smoked 
than when cocaine hydrochloride is insufflated (Jones, 1990; Hatsukami and Fischman, 
1996). In human laboratory studies, faster rates of drug delivery produce greater feelings 
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of euphoria with a variety of drugs, including orally administered pentobarbital (de Wit et 
al., 1992), i.v. morphine (Marsch et al., 2001), and cocaine (Resnick et al., 1977; 
Fischman, 1984; Volkow et al., 2000; Abreu et al., 2001; Nelson et al., 2006). Indeed, 
these results support the widely held hypothesis that faster rates are more addicting – they 
increase the rewarding properties of the drug (Gorelick, 1998). Some animal studies have 
supported this hypothesis. In non-human primates, increasing the rate of drug infusion 
increases the reinforcing effects of cocaine over several different schedules of 
reinforcement, including during fixed interval (Balster and Schuster, 1973), fixed ratio 
(Kato et al., 1987; Panlilio et al., 1998), and progressive ratio schedules of reinforcement 
(Woolverton and Wang, 2004). However, in some of these studies, the rate of drug 
delivery varied to such an extent that the total amount of drug to reach the brain also 
varied, confounding these two factors. This topic will be discussed in more detail below. 
Faster rates of drug infusion may induce changes in processes in the brain 
sensitizing incentive motivation 
In addition to producing greater euphorigenic effects, Samaha and Robinson 
(2005) have suggested that faster rates of drug delivery can also preferentially engage and 
alter the brain, so that systems that mediate the attribution of incentive motivational 
salience become sensitized – leading to an increased ―wanting‖ of drug or drug related 
cues.  
When given repeated and intermittent injections of cocaine, animals exhibit a 
progressive increase in psychomotor activation to the same dose of drug (Magos, 1969; 
Wallach and Gershon, 1971; Segal and Mandell, 1974; Post and Rose, 1976; Eikelboom 
and Stewart, 1982; Robinson, 1984; Robinson and Becker, 1986). With repeated 
injections of a relatively low dose, there is a progressive increase in drug-induced 
locomotion with each successive treatment (Robinson & Berridge 1993). At more 
moderate doses, similar treatment will begin to elicit an increase in stereotyped 
behaviors, even when the initial response to the drug is limited to an increase in 
locomotion (Robinson & Berridge 1993). Similar changes in behavior have also been 
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observed as a consequence of self-administration (Phillips and Di Ciano, 1996; De Vries 
et al., 1998; Zapata et al., 2003; Ferrario et al., 2005).  
This sensitization to the psychomotor activating effects of cocaine (psychomotor 
sensitization) is thought to be a behavioral symptom of persistent and long term 
neuroadaptations in brain systems that are also thought to be important in mediating 
incentive motivational processes (Robinson and Berridge, 1993, 2000). In support of this 
idea, rats previously sensitized to cocaine acquire cocaine self-administration at lower 
doses than control animals (Horger et al., 1990), exhibit greater response for conditioned 
rewards (Taylor and Horger, 1999), and show greater motivation for cocaine (Lorrain et 
al., 2000) under a progressive ratio schedule of reinforcement. Rats previously sensitized 
to amphetamine, cocaine or morphine also show enhanced conditioned place preferences 
to the same drug, relative to control animals (Lett, 1989; Shippenberg and Heidbreder, 
1995). Effects of one drug can generalize in some cases to other drugs. For example, 
animals previously sensitized to amphetamine will show cross-sensitization in 
locomotion when subsequently tested with cocaine (Schenk et al., 1991; Hooks et al., 
1992; Bonate et al., 1997), suggesting a common neural substrate (Robinson and 
Berridge, 1993). 
If sensitization of incentive motivational processes (i.e. incentive sensitization) 
underlies addiction, and faster rates of drug delivery are more addicting, then faster rates 
should be more effective in producing psychomotor sensitization. This hypothesis was 
tested by Samaha and colleagues in a series of studies by examining the effects of rate of 
drug delivery on psychomotor sensitization. 
Faster rates of infusion are associated with psychomotor sensitization 
In an initial study examining the influence of rate of drug delivery on 
sensitization, Samaha and colleagues (2002) found that faster rates of cocaine delivery 
are more effective in inducing psychomotor sensitization, as assessed by locomotor 
activity in neurologically intact rats or by rotational behavior in rats with unilateral 
lesions of the nigrostriatal dopamine system (Ungerstedt and Arbuthnott, 1970). 
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Rotational behavior in lesioned rats is an especially sensitive indicator of sensitization 
(Robinson, 1984; Crombag et al., 1999). Samaha et al. (2002) reported that faster i.v. 
injections (3 – 16 sec) of 1.0 mg/kg of cocaine during 7 daily treatments produced greater 
sensitization of rotational behavior by the 7th and last day of treatment than slower rates 
(37 sec). After 5 days of withdrawal, only rats treated with faster rates (3 – 16 sec) 
expressed a sensitized response to a challenge infusion of either 5 sec or 34 sec. In 
neurologically intact rats, rats pretreated with a total of 5 rapid (5 sec) infusions of 
cocaine spaced several days apart showed a sensitized locomotor response to a challenge 
infusion of cocaine after 4 days of withdrawal across a range of treatment doses (0.5 – 2 
mg/kg). In contrast, animals that had been treated with drug over 45 and 90 sec only 
showed a sensitized response to a challenge dose when their pretreatment doses were 2.0 
mg/kg. 
The results of this experiment showed by using two different behavioral measures 
that variation in the rate of cocaine delivery over a relatively narrow range (3 – 100 sec) 
had a large effect on its ability to induce psychomotor sensitization, and therefore, 
presumably to produce the changes in brain responsible for this form of drug-induced 
plasticity. 
The effects of varying rate of infusion on behavior and neurobiology over 5 
to 100 sec are not due to differences in the amount of drug reaching the 
brain 
Variation in i.v. cocaine delivery between 5 –100 sec is similar to the variation in 
rates that addicts report when injecting drugs (Zernig et al., 2003), captures the variation 
between snorting and smoking (Jones, 1990), and influences the subjective effects of 
cocaine (Abreu et al., 2001). A very simple explanation for these effects of drug delivery 
on psychomotor sensitization is that different amounts of cocaine reach the brain, raising 
the possibility that the rate of cocaine delivery could be conflated with dose effects. 
However, this is not the case. First, the pharmacokinetics of cocaine are such that varying 
an i.v. injection between 5 and 100 sec has no effect on the peak amount of cocaine to 
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reach the brain; see Fig. 1.1 adapted from Samaha et al., (2002); also see Shou et al., 
(2006). With faster infusions, cocaine levels reach their peak levels more rapidly, as 
would be expected; but there is no difference in the peak or the total amount of cocaine in 
brain when rate of infusion is varied between 5 and 100 sec.  
Within the brain, cocaine binds to monoamine transporters, preventing reuptake, 
and thereby increasing the synaptic concentration of dopamine, serotonin, and 
norepinephrine (Heikkila et al., 1975; Ritz et al., 1987; Giros and Caron, 1993). In 
particular, its effects on dopamine neurotransmission in the dorsal and ventral striatum 
are thought to be especially important in producing both its psychomotor activating and 
reinforcing effects (Roberts et al., 1977; Roberts et al., 1980; Ritz et al., 1987; Wise and 
Bozarth, 1987; Di Chiara and Imperato, 1988; Camp et al., 1994). Thus the influence of 
cocaine on dopamine ―overflow‖ in the striatum is tightly coupled to its levels in brain 
(Shou et al., 2006), and therefore one can also ask how the rate of drug delivery 
influences dopamine levels measured with microdialysis. Microdialysis coupled with on-
line capillary electrophoresis and laser induced florescence detection provides the ability 
to measure dopamine levels with reasonably good temporal resolution (one sample every 
90 sec). Using this procedure, Ferrario et al. (2008) recently reported that cocaine given 
over either 5 or 100 sec proportionately increased dopamine to the same levels in the 
striatum. As expected from cocaine pharmacokinetics, after a 5 sec infusion, dopamine 
levels peaked faster than after a 100 sec infusion, but there was no difference in either 
peak dopamine levels or total dopamine overflow (as measured by area under the curve). 
(Fig 1.1– also see Shou et al., 2006) 
Repeated cocaine and psychomotor sensitization are associated with 
neurobiological changes in the striatum 
Although variation in the rate of drug delivery between 5 – 100 sec results in 
large differences in psychomotor sensitization, these differences are not due to 
differences in brain dopamine levels. This suggests that faster rates of drug delivery must 
influence other neurobiological actions of cocaine. 
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Animals with a history of chronic cocaine treatment and expressing psychomotor 
sensitization also have persistent and extensive neurobiological changes in the 
mesocorticolimbic circuit. For example, repeated non-contingent cocaine treatment is 
associated with potentiated release of dopamine in the dorsal and ventral striatum after a 
cocaine challenge (Akimoto et al., 1989; Kalivas and Duffy, 1990; Pettit et al., 1990; 
Keller et al., 1992), an effect blocked by dopamine antagonists (Weiss et al., 1989; 
Kalivas and Stewart, 1991). Microinjections of amphetamine into the ventral tegmental 
area directly can lead to psychomotor sensitization (Kalivas and Weber, 1988; Vezina 
and Stewart, 1990; Hooks et al., 1993; Perugini and Vezina, 1994; Cador et al., 1995; 
Vezina, 1996) and increased motivation for cocaine during subsequent self-
administration under a progressive ratio schedule. An enhanced dopamine release upon a 
drug challenge is also seen (Vezina, 2004).  
Although much of the research on this topic has focused on dopamine, it is 
important to emphasize that repeated administration of cocaine produces long-lasting 
changes in nearly every neurotransmitter system studied within these mesocorticolimbic 
circuits, including norepinephrine, serotonin, acetylcholine, amino acid transmitters, 
opioid peptides, and many others (Goodman, 2008). This may be because cocaine 
fundamentally alters the organization of these circuits, as indicated by changes in 
dendritic spine density and dendritic branching on MSNs in both the dorsal and ventral 
striatum, and pyramidal cells in the frontal cortex (Robinson and Kolb, 2004). This form 
of structural plasticity suggests that repeated exposure to cocaine alters patterns of 
synaptic connectivity in these brain regions.  
In addition, repeated treatment (both non-contingent and self-administration) 
influences immediate early gene expression in mesocorticolimbic circuits. This will be 
detailed further in the following sections.  
Immediate early gene expression as a marker for neurobiological impact 
One frequently used measure of the neurobiological impact of drugs is their 
ability to alter the expression of immediate early genes (IEGs) such as c-fos (Sagar et al., 
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1988; Harlan and Garcia, 1998). The Fos protein is a 55 or 62 kilodalton (kD) 
chromosomal transcription factor (Curran and Teich, 1982; Morgan and Curran, 1991) 
derived from the c-fos gene in the human and mouse genome (Curran et al., 1983), 
identified as the native homolog of the viral oncogene Finkel-Biskis-Jinkin (FBJ) Murine 
osteosarcoma virus (v-fos) (Curran et al., 1982).  
Its suitability as a marker for biochemical activation arises from several common 
characteristics shared with other IEGs. Besides psychoactive drugs, neurons express c-fos 
rapidly after many different stimuli such as electrical stimulation (Sagar et al., 1988), 
nociceptive stimulation, heat stress and light stimulation (Morgan and Curran, 1991). c-
fos induction is both transient and rapid (Hughes and Dragunow, 1995). For example, c-
fos mRNA transcription occurs within 5 minutes and continues for 15-20 minutes, while 
Fos protein expression generally has a half-life of two hours (Morgan and Curran, 1991). 
c-fos expression is also independent of upstream protein synthesis (Sheng and Greenberg, 
1990), indicating that the factors initiating the transcription of IEGs are pre-existing in 
the neuron, constitutively expressed, and activated by some method of post-translational 
modification (Hughes and Dragunow, 1995). In this way, c-fos expression has been 
hypothesized to couple acute stimuli received at the neuron's surface to longer term 
neuroadaptations by regulating gene expression (Sheng and Greenberg, 1990; Morgan 
and Curran, 1991). It should be noted that while Fos expression as a marker for brain 
activity and ―activation‖ has many advantages, including high spatial resolution, its 
temporal resolution is low and should not be considered synonymous with increased 
neurophysiological activity (Kovacs, 2008).      
Fos expression as a transcription factor initiating changes in the brain 
Although IEG activation has been used primarily as a marker to map neurons 
biochemically activated after a stimulus (Sagar et al., 1988; Harlan and Garcia, 1998), the 
native role of Fos protein is as a transcription factor modulating a gene cascade linked to 
longer term neuroadaptations (Sheng and Greenberg, 1990; Morgan and Curran, 1991). 
Once synthesized, Fos protein forms heterodimers with Jun, another IEG protein, and 
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these heterodimers form activator protein complexes (AP-1) that bind to AP-1 binding 
sequences upstream of genes targeted for regulation (Morgan and Curran, 1991).  
Chronic cocaine treatment may upregulate genes in D1-expressing MSNs that 
have AP-1 binding domains, including genes implicated in the dendritic reorganization of 
neurons (IGFBP6 and SDF1). This suggests that genes possibly targeted by Fos induction 
may also play a role in the enduring neurobiological changes associated with 
psychomotor sensitization (Zhang et al., 2005). Indeed, of particular relevance to the 
topic of this thesis, Zhang and colleagues (2006) recently found that the transgenic 
deletion of the c-fos gene in D1 receptor expressing striatal MSNs attenuated 
psychomotor sensitization and many of the associated neurobiological adaptations 
associated with it, including structural changes in MSN dendrites. 
Thus, in addition to being a biochemical marker for neuronal activation, increased 
cocaine induced Fos expression in the striatum is functionally associated with the 
neurobiological adaptations of psychomotor sensitization. 
Fos expression in the mesocorticolimbic system is upregulated by acute 
drug exposure 
Acute exposure to many drugs of abuse increases c-fos gene expression in the 
intact brain. Neurons within the mesocorticolimbic system in particular express Fos in 
response to amphetamine (Graybiel et al., 1990; Young et al., 1991), cocaine (Graybiel et 
al., 1990; Young et al., 1991; Samaha et al., 2004), nicotine (Matta et al., 1993; Sharp et 
al., 1993; Kiba and Jayaraman, 1994; Samaha et al., 2005) and morphine (Chang et al., 
1988; Liu et al., 1994; Garcia et al., 1995; Curran et al., 1996). Although each drug 
appears to induce Fos expression in unique patterns, suggesting that distinct cells within 
the circuit are biochemically activated (Harlan and Garcia, 1998), common changes to 
components of the mesocorticolimbic circuit by drugs of abuse, including cocaine, are 
believed to be a factor contributing towards the development of neural changes that may 
contribute to addiction (Robinson and Berridge, 1993; Hyman and Malenka, 2001).  
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Increased Fos expression in the striatum from acute cocaine is dependent 
on striatal dopamine  
The induction of Fos expression by cocaine is largely dependent on dopamine, 
although other neurotransmitters can influence induction as well (Torres and Rivier, 
1993; Couceyro et al., 1994; Szucs et al., 2005). Pretreatment with the dopamine D1 
antagonist SCH-23390 results in a marked attenuation of Fos in the dorsal and ventral 
striatum (Graybiel et al., 1990; Young et al., 1991), and mutant mice with D1 receptor 
deletions have severely attenuated Fos expression after a cocaine challenge (Moratalla et 
al., 1996). Experiments suggest that D2 and D3 receptors may also play a role in 
modulating cocaine-induced Fos expression (Dilts et al., 1993; LaHoste et al., 1993; 
Ruskin and Marshall, 1994; Carta et al., 2000). 
It should be noted that the majority of other drugs commonly abused by humans 
also increase dopamine in the striatum. In addition to cocaine, changes in dopamine have 
been observed with amphetamine (Di Chiara and Imperato, 1988), nicotine (Clarke and 
Pert, 1985), alcohol (Gessa et al., 1985; Mereu and Gessa, 1985), morphine (Matthews 
and German, 1984), and methylenedioxymethamphetamine (MDMA, but only the S(+)-
enantiomer, see Fantegrossi, 2008). For this reason, dopamine is thought to play a critical 
role in reward and incentive motivational processes key in addiction, and is considered 
the major common mechanism by which drugs of abuse act in the brain and impact c-fos 
expression (Wise and Bozarth, 1987; Di Chiara and Imperato, 1988; Koob, 1992; 
Robinson and Berridge, 1993; Robbins and Everitt, 1996; Berridge and Robinson, 1998; 
Harlan and Garcia, 1998; Robinson and Berridge, 2000; Hyman and Malenka, 2001; 
Berridge and Robinson, 2003; Berridge et al., 2009). 
Faster rates of infusion that can induce psychomotor sensitization have a 
greater acute impact on c-fos expression the brain  
Samaha and colleagues (2004) demonstrated in rats that rapid rates of drug 
infusion (5 sec) capable of inducing psychomotor sensitization were associated with a 
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greater neurobiological impact on the brain. In one experiment, rats given a single acute 
infusion of cocaine over 5 sec – capable of inducing psychomotor sensitization in one day 
– showed greater c-fos and arc mRNA expression in specific regions of the brain. Areas 
of specifically high c-fos upregulation were parts of the mesocorticolimbic circuit, 
including portions of the medial prefrontal cortex (particularly the infralimbic cortex), the 
core and shell subdivisions of the nucleus accumbens in the ventral striatum, and the 
dorsomedial and dorsolateral subregions of the dorsal striatal division. Fos expression in 
the dorsal and ventral divisions also varied rostrocaudally. In the dorsal striatum, 5 sec 
infusions induced a pattern of expression where the caudal extent of the striatum had the 
highest expression. Conversely, the rostral extent of the nucleus accumbens had the 
greatest amount of c-fos expression.  
Thus, faster rates of cocaine delivery were not only more effective in inducing 
sensitization, but also in initiating what is thought to be a key initial step for drug-induced 
neuroplasticity – the induction of IEGs. Furthermore, the pattern of c-fos expression 
suggested that specific functionally distinct nuclei projecting to the areas sampled 
(Willuhn et al., 2003) were being engaged by faster rates of cocaine.  
The striatum is a heterogeneous structure which is part of a larger 
mesocorticolimbic circuit 
Although Samaha and colleagues (Samaha et al., 2004) demonstrated that faster 
rates of an acute infusion results in greater Fos expression in the striatum, it is not a 
homogeneous structure. The striatum is a relatively large brain region embedded within 
mesocorticolimbic circuits, a reentrant loop of interconnected brain nuclei (Alheid and 
Heimer, 1988; Heimer and Van Hoesen, 2006) sharing general cellular and anatomical 
characteristics with other corticothalamic circuits (Zahm, 2006). 
A major site of action of cocaine in this region includes synapses between 
dopamine neurons and the projection neurons in the striatum, the medium spiny neurons 
(MSNs). The dorsal striatum is innervated by dopamine cells located primarily in the 
substantia nigra and the ventral striatum (the nucleus accumbens) is innervated by 
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dopaminergic cells mainly from the ipsilateral ventral tegmental area (Ungerstedt, 1971; 
Fallon and Moore, 1978; Swanson, 1982; Tanaka et al., 1982; Alheid and Heimer, 1988). 
Although most drug related studies have focused on the nucleus accumbens, the dorsal 
striatum also plays a role in goal-directed behaviors as well (Yin et al., 2008).  
In addition to dopaminergic input, MSNs in the striatum also receive excitatory 
glutamatergic input originating from pyramidal cells in layer 5 of the cortex (Glees, 1944; 
Webster, 1961, 1965; Reynolds and Zahm, 2005). MSNs receive glutamate input onto the 
heads of their spines, while receiving dopamine input on the necks of their spines 
(Totterdell and Smith, 1989; Sesack and Pickel, 1990; Meredith et al., 1999). This 
synaptic arrangement between glutamate and dopamine may allow an interaction 
modulating MSN activity (Smith and Bolam, 1990) and influencing output targets 
(Gerfen, 1992; Heimer and Van Hoesen, 2006).  
 The striatum is organized by subregions and subcompartments 
MSNs in the striatum use γ-aminobutyric acid (GABA) as a neurotransmitter 
(Ribak et al., 1979; Kita and Kitai, 1988), and appear to be anatomically homogeneous 
(Kemp and Powell, 1971; Wilson and Groves, 1980). However, they are organized into 
complex and heterogeneous subregions that can be further classified into several distinct 
yet overlapping systems. This is of interest because acute cocaine injections have 
previously been shown to preferentially influence neurons in specific striatal subregions, 
suggesting that different functional areas of the striatum are activated in response to 
cocaine (Willuhn et al., 2003).  
MSNs in the dorsal striatum and nucleus accumbens can be characterized along 
the rostrocaudal and mediolateral axis into subregions based on their glutamatergic 
innervation from functionally different areas of cortex (Webster, 1961; McGeorge and 
Faull, 1989; Berendse et al., 1992; Willuhn et al., 2003). For example, Willuhn and 
Steiner (2003) characterized 26 distinct striatal subregions based on a review of tract-
tracing studies and functional mapping studies based on electrophysiology. They found 
that dorsal lateral portions of the striatum along the rostromedial axis receive glutamate 
afferents predominantly from the sensorimotor cortex, while dorsal medial portions 
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receive inputs primarily from the agranular cortex. In the ventral striatum, the core of the 
nucleus accumbens receives distinctly different input from the shell (Heimer et al., 1997; 
Willuhn et al., 2003). Generally, the core receives input primarily from prelimbic and 
agranular cortex, while the medial shell region receives its input primarily from the 
infralimbic and prelimbic cortex (Willuhn et al., 2003).  
Acute cocaine injections have a greater neurobiological impact on gene 
expression in dorsal areas of the striatum, suggesting that functionally distinct cortical 
areas are being preferentially activated by cocaine (Willuhn et al., 2003). For example, 
lesions in the dorsal medial subregions of the striatum impact outcome devaluation, 
suggesting a role in goal directed learning (Yin et al., 2005). Dorsolateral subregions of 
the striatum are thought to play a role in mediating habitual responses to stimuli (Yin et 
al., 2004). 
In the ventral striatum, acute cocaine has a greater neurobiological impact on gene 
expression on the shell of the accumbens than the core (Willuhn et al., 2003). 
Functionally, the shell of the nucleus accumbens may mediate the motivational impact of 
unconditioned stimuli like cocaine, while the core of the accumbens has been suggested 
to play a role in mediating the motivational impact of Pavlovian conditioned stimuli, or 
previously neutral stimuli that has been repeatedly paired with rewarding unconditioned 
stimuli (Cardinal, 2003). 
In addition to subregions, the striatum (primarily the dorsal division) is also 
organized into biochemically distinct subcompartments. The striosome or ―patch‖ 
compartment has a relatively high density of mu opioid receptors (Pert et al., 1976; 
Herkenham and Pert, 1980; Graybiel et al., 1981; Herkenham and Pert, 1981; Gerfen, 
1992, 1992) whereas the surrounding matrix compartment is enriched with 
acetylcholinesterase (Graybiel and Ragsdale, 1978) and calbindin (Gerfen, 1985). 
Neurons in the patch are distinct from matrix neurons in many ways. During 
development, patch neurons arise earlier and have different patterns of migration during 
development than matrix neurons (van der Kooy and Fishell, 1987; Song and Harlan, 
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1994; Heimer et al., 1997). Patch neurons also have distinct neurophysiological 
characteristics (Miura et al., 2007).  
Importantly, studies have suggested that glutamatergic cortical input into the 
patch and matrix compartments are partially segregated by both topography and by 
laminar origin within the cortex (Gerfen, 1984, 1989). Neurons in the patch receive input 
primarily from the prelimbic and infralimbic cortices (Gerfen, 1984) and the matrix 
receives afferents from the somatosensory and motor cortices (Donoghue and 
Herkenham, 1986). In addition, patch afferents originate from different layers of the 
cortex. Patches arise from neurons in Layer IV and deep Layer V of cortex, whereas 
matrix afferents originate from superficial layers of Layers III and V (Gerfen, 1989). The 
complexity of inputs suggests that striosomes represent distinct functional units in the 
dorsal striatum. Several studies support this hypothesis. For example, electrical 
stimulation of the striosome compartment is more reinforcing than stimulation in the 
matrix compartment (White and Hiroi, 1998), and animals with targeted striosomal 
ablations exhibit performance deficits on an accelerating rotarod, a complex motor task 
(Lawhorn et al., 2009). Importantly, repeated cocaine treatment shifts gene expression 
patterns so that genes important for long-term neuroadaptations express to a greater 
extent within the patch subcompartment. This will be described in the following section.  
In summary, the striatum is a complex structure made up of subregions that are 
differentially influenced by cocaine (Willuhn et al., 2003). Increases in activity in 
specific areas and compartments of the striatum may be associated with the activation of 
functionally distinct areas of the brain, and will be taken into account in the following 
studies. 
The effect of chronic cocaine treatment on Fos expression in the brain 
Shifts in c-fos expression to the patch subcompartment relative to the matrix 
One neuroadaptation associated with psychomotor sensitization to cocaine is a 
shift in c-fos expression to the patch subcompartment relative to the matrix (Graybiel et 
al., 1990; Moratalla et al., 1996; Tan et al., 2000), although in these studies the shift was 
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due to a relative decrease in the matrix rather than an increase in the patch. However, 
following extended withdrawal Jedynak and colleagues found that an amphetamine 
challenge increased Fos preferentially in the patch compartment in the dorsal striatum 
(Doctoral dissertation; unpublished, 2009). Since Fos expression patterns in the striatum 
may reflect the biochemical activation of distinct functional areas of the 
mesocorticolimbic circuit, this may reflect a change in the relative dominance of the 
patch vs. matrix subcompartments. One question examined in Chapter 2 of this 
dissertation was whether faster rates of an acute infusion induce greater Fos protein 
expression in the patch versus the matrix subcompartment.  
Chronic treatment is associated with desensitization of c-fos expression 
In addition to shifts in the pattern of c-fos expression, chronic cocaine treatment 
typically results in an enduring desensitization of c-fos expression to a cocaine challenge 
in both the nucleus accumbens and dorsal striatum (Hope et al., 1992; Steiner and Gerfen, 
1993; Couceyro et al., 1994; Daunais and McGinty, 1994; Rosen et al., 1994; Moratalla 
et al., 1996; Willuhn et al., 2003), and this is also seen after self-administration (Daunais 
et al., 1995). It is important however to note that in some cases it has also been reported 
that prior cocaine experience can enhance Fos expression in the nucleus accumbens 
produced by a drug challenge, although this is only seen after a long period of drug 
abstinence (Crombag et al., 2002; Todtenkopf et al., 2002), and only if cocaine was 
administered in association with environmental novelty (Hope et al., 2006). However, 
this hypersensitivity is not always seen (e.g. Ostranader et al., 2003; Willuhn et al., 
2003), and it is not clear exactly what conditions lead to a sensitization vs. desensitization 
of the Fos response, even following extended abstinence.  
Faster rates of nicotine infusions during chronic treatment induce a persistent 
suppression of c-fos expression in the brain 
Although there have been no studies examining how varying the rate of cocaine 
delivery during chronic treatment impacts c-fos expression, Samaha and colleagues 
(2005) did investigate the influence of rate of infusion on psychomotor sensitization to 
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nicotine and the effect of chronic treatment on IEG expression in the mesocorticolimbic 
circuit. While an extensive review of nicotine and its effects are beyond the scope of this 
introduction, two key similarities between cocaine and nicotine should be stressed 
beyond their shared addictive potential (Balfour, 1990). First, cocaine and nicotine 
administration share the ability to facilitate the development of psychomotor sensitization 
(Stolerman et al., 1973; Clarke and Kumar, 1983; Ksir et al., 1985; Miller et al., 2001). 
Second, acute exposure to nicotine has similar abilities to induce c-fos gene expression in 
the mesocorticolimbic circuit (Matta et al., 1993; Kiba and Jayaraman, 1994). 
In one experiment, Samaha and colleagues (2005) showed that 50 µg/kg nicotine 
infused over 5 sec was able to induce greater psychomotor sensitization than nicotine 
delivered more slowly (25 – 100 sec), resembling the results of the cocaine experiment 
(2004). In a second experiment, nicotine was delivered over 5 sec after a chronic 
treatment regimen (5 serial infusions of 50 µg/µL nicotine equally spaced over 10 
minutes over 6 consecutive days). Following 4 drug-free days, the ability of a subsequent 
nicotine challenge to induce c-fos was diminished in both the dorsal striatum and the shell 
division of the nucleus accumbens. 
The results of this experiment showed that rapid rates of nicotine administration 
can induce psychomotor sensitization, and that faster rates of infusions during chronic 
treatment can have an enduring impact on its ability to induce c-fos expression in the 
mesocorticolimbic circuit. 
Rate of infusion and cocaine self-administration: effects unclear 
Given the results of the previous studies and the importance of rate of infusion in 
human addiction, one would expect a clear effect on rat cocaine self-administration. 
However, studies examining the influence of rate of infusion on self-administration in the 
rat have been largely negative. In the first study describing the influence of rates of 
cocaine infusion on cocaine self-administration, Pickens and colleagues (1969) found no 
differences in drug-taking behavior when cocaine was delivered over 25 to 75 sec. In our 
laboratory, Crombag and colleagues (2008) found that 100 sec infusions of cocaine in 
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comparison to 5, 25, or 50 sec infusions slightly decreased the reinforcing properties of 
cocaine in animals well trained to self-administer cocaine under a continuous schedule of 
reinforcement (FR1). However, when animals were retrained to self-administer under a 
fixed ratio 2 schedule of reinforcement (FR2), the rate of cocaine infusion did not 
influence cocaine reinforcement. In addition, no effects of rate of infusion were found on 
the acquisition of self-administration of either cocaine or amphetamine over a range of 
doses – rats receiving their infusions over 100 sec acquired self-administration equally 
well as the animals receiving the drug over 5 sec. Likewise, varying the rate of 
amphetamine or cocaine infusion had no impact on self-administration on a progressive 
ratio schedule of reinforcement – rats were equally motivated to take drug delivered over 
100 sec or 5 seconds. Finally, the rate of amphetamine or cocaine infusion had no impact 
on drug-primed reinstatement of drug seeking behavior.  
Given these results, a plausible hypothesis might be that rats cannot discriminate 
between these relatively short infusion rates. However, Schindler and colleagues (2009) 
demonstrated that rats can discriminate between different rates of cocaine infusion in this 
range (1.7 – 100 sec). In one experiment, when given the choice between a nosepoke 
delivering cocaine over 1.7 sec or 100 sec during self-administration, rats preferred faster 
rates of infusion. When the association between the nosepoke and rate of infusion was 
reversed (e.g. the nosepoke previously delivering cocaine over 1.7 sec now delivered the 
same dose over 100 sec), rats reversed their preference to some degree. 
Another study has shown that rats with a fairly extensive history of self-
administration under a progressive ratio schedule of reinforcement gradually increased 
their breakpoints across successive sessions if their drug is delivered over 5 sec, but not 
when delivered over 25 or 50 sec (Liu et al., 2005). In this study, animals trained at a 
faster rate of infusion maintained elevated breakpoints even when the rate of infusion was 
lowered in subsequent test sessions, presumably showing a persistent sensitized 
motivation and increased willingness to work for drug. Yet when these animals were 
retested after their progressive ratio experience, varying the rate of infusion of cocaine 
during an FR1 schedule did not influence drug-taking behavior, despite groups having 
23 
 
different rate of infusion histories. Consistent with the studies by Crombag et al. (2008), 
Liu and colleagues suggested that rate of infusion had no effect on the acute reinforcing 
effects of cocaine.  
How can these negative results on the effect of rate of cocaine delivery on self-
administration behavior in the rat be reconciled with the preponderance of evidence that 
in humans the rate that drugs reach the brain is an important factor in its addictive 
liability? Perhaps one reason might be that the ability of faster rates of cocaine to foster 
addiction is not directly related to its greater reinforcing effects. 
As discussed in the beginning of this introduction, while addiction liability in 
humans has primarily been determined by testing its reinforcing effects, drug-taking is 
only one of the many symptoms associated with addiction. This perhaps is the reason 
why experiments testing the addictive liability of faster rates of drug infusions on rat self-
administration have been unclear; testing its reinforcing effects may not adequately 
model its effects as a factor influencing addiction. After all, animals given access to 
cocaine under limited access have long been known to show well regulated intake 
(Wilson et al., 1971; Johanson, 1984). Recently, extended access self-administration 
procedures that are thought to better model aspects of human addiction have been 
developed.  
Extended access self-administration 
Extended access procedures differ from conventional self-administration sessions 
by either allowing many more sessions (Deroche-Gamonet et al., 2004; Belin et al., 
2008), providing increased access per day by lengthening each session (Ahmed and 
Koob, 1998; Vanderschuren and Everitt, 2004), or both (Ahmed and Koob, 1999). When 
rats are given extended access to drugs, some of them begin to manifest many striking 
behavioral symptoms resembling human addiction (Gawin and Kleber, 1988; Gawin and 
Ellinwood, 1989). Compared to animals only given limited access to drug, rats given 
extended access begin taking increasingly greater amounts of drug over the entire 
session. Some researchers have also reported a concomitant escalation during the first 
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hour of the session (Ahmed and Koob, 1998, 1999; Ahmed et al., 2002; Ben-Shahar et 
al., 2004; Ferrario et al., 2005; Knackstedt and Kalivas, 2007; Briand et al., 2008). This 
marked increase in drug intake is accompanied by other addiction-like symptoms. For 
example, rats become increasingly resistant to aversive stimuli related to drug, either 
when it is presented simultaneously with drug reward (Deroche-Gamonet 2004), or when 
it is explicitly paired with the act of seeking drug (Vanderschuren and Everitt, 2004; 
Pelloux et al., 2007). Some of these rats show greater motivation for drug when tested on 
a progressive ratio schedule of reinforcement (Paterson and Markou, 2003; Deroche-
Gamonet et al., 2004; Belin et al., 2008) and they persist in seeking drug even when they 
know it is not available (Deroche-Gamonet et al., 2004; Ferrario et al., 2005). Rats with 
extended access to cocaine develop ―burst-like‖ patterns of rapid drug-taking that may 
lead to faster and greater delivery of drug to the brain (Belin et al., 2009). Additionally, 
some rats given extended access to cocaine self-administration also show a greater 
propensity to reinstate cocaine seeking behavior after extinction (Deroche-Gamonet et al., 
2004; Mantsch et al., 2004; Ferrario et al., 2005; Kippin et al., 2006; Knackstedt and 
Kalivas, 2007; Belin et al., 2008; Belin et al., 2009). As is the case in humans, rats with a 
history of extended access to cocaine self-administration often manifest many of these 
addiction-like symptoms together. In summary, extended access procedures result in the 
development of a number of addiction-like symptoms, and thus may better model 
changes in brain and behavior associated with addiction in humans (Robinson, 2004).  
I hypothesize, therefore, that these procedures may reveal effects of rate of drug 
delivery that are not evident when using more conventional limited access self-
administration sessions because they are not especially effective in producing symptoms 




Hypotheses and Specific Aims 
1. The aim of the first study in this dissertation was to confirm and quantify the 
influence of rate of cocaine delivery on Fos protein expression, extending the findings of 
previous studies which showed that faster rates of an acute infusion of cocaine can induce 
greater c-fos mRNA in the mesocorticolimbic system and induce greater psychomotor 
sensitization (Samaha et al., 2002; Samaha et al., 2004). To pursue this aim, I first 
determined if the rate of cocaine delivery affected Fos protein in a similar fashion to 
mRNA, as recent studies suggested Fos protein expression was required for cocaine to 
produce psychomotor sensitization and related changes in the organization of MSN 
dendrites. Second, I sought to determine if the effect of rate of cocaine delivery on the 
number of Fos positive cells was specific to the striosomal ―patch‖ compartments.  
2. The second study in this dissertation focused on determining the influence of 
rate of cocaine delivery on self-administration behavior when animals were provided 
extended access to the drug. To the extent that rate of drug delivery influences the 
transition to addiction, I hypothesized that an effect may be evident only under conditions 
that lead to the development of addiction-like symptoms (Ahmed and Koob, 1998; 
Robinson, 2004; Samaha and Robinson, 2005). Thus, I compared the influence of rate of 
i.v. cocaine delivery on self-administration behavior when animals were allowed access 
to cocaine for only 1 hr each day (―short access,‖ ShA) or for 6 hrs each day (―long 
access,‖ LgA). 
3. The third study involved rats with a history of extended access to rapidly 
infused cocaine. Under limited access conditions, we previously saw no effect of rate of 
cocaine delivery on cocaine-induced reinstatement (Crombag et al., 2008). Thus, one aim 
tested whether the rats would persist in seeking drug during extinction and reinstate their 
drug seeking behavior when primed with cocaine to a greater degree than animals with a 
similar self-administration experience but with slower rates of drug delivery. The second 
aim of this study tested the hypothesis that rats with a history of rapid infusions during 








Fig. 1.1 Panel a: A pharmacokinetic model of predicted cocaine concentration (µM) in 
the brain of a 300 g rat after a 1.0 mg/kg injection. Successive curves show the time to 
peak and peak levels of cocaine with infusion rates over 5, 25, 50, and 100 sec (from left 
to right, respectively) used in these experiments. Note no difference in peak concentration 
of cocaine over this range of rates. Figure adapted from Samaha et al. (2002). Panel b: 
The mean concentration of extracellular dopamine in the striatum after an acute infusion 
of 2.0 mg/kg cocaine given either over 5 or 100 sec. Arrow indicates the time of the 
infusion. Note that similar to the predicted concentration of cocaine shown in Panel a, the 
peak concentration of dopamine released by cocaine over these rates of delivery does not 
differ – only the time to peak differs across these rates. The total amount of dopamine (as 
expressed by area under the curve) also does not differ across these rates (data not 










THE INFLUENCE OF THE RATE OF INTRAVENOUS COCAINE DELIVERY 
ON FOS EXPRESSION IN SUBREGIONS AND SUBCOMPARTMENTS OF 
THE STRIATUM 
Introduction 
The time it takes drugs such as cocaine to reach the brain is thought to be an 
important factor in determining its abuse liability (Hatsukami and Fischman, 1996), but 
there is very little research on how rate of cocaine delivery influences its neurobiological 
actions (Samaha and Robinson, 2005). Previous work has shown that faster rates of drug 
administration, while delivering the same amount of drug to the brain and inducing 
similar peak levels of dopamine efflux in the brain (Pan et al., 1991; Samaha et al., 2002; 
Ferrario et al., 2008), nonetheless are more effective than slower rates in producing 
psychomotor sensitization and inducing immediate early gene expression (Samaha et al., 
2002; Samaha et al., 2004; Samaha et al., 2005), as well as in altering brain temperature 
(Brown and Kiyatkin, 2005). The induction of psychomotor sensitization by faster rates 
of drug administration is considered a behavioral symptom of long lasting 
neurobiological alterations in brain circuits that may contribute to the transition to 
addiction (Samaha and Robinson, 2005). 
The use of immediate early gene (IEG) expression is a well established method of 
mapping brain activation and the biochemical response of neurons to a number of stimuli, 
including drugs of abuse (Sagar et al., 1988; Hughes and Dragunow, 1995; Harlan and 
Garcia, 1998). Indeed, many researchers have shown that the mRNA for the prototypical 
IEG, c-fos (Curran et al., 1982; Curran and Teich, 1982), is upregulated in the 
mesocorticolimbic system, a circuit in the brain critical to addiction (Robinson and 
Berridge, 1993; Hyman and Malenka, 2001; Robinson and Berridge, 2003; Kalivas and 
Volkow, 2005) by the administration of drugs such as amphetamine, methamphetamine, 
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cocaine, morphine, and nicotine (Chang et al., 1988; Graybiel et al., 1990; Young et al., 
1991; Persico et al., 1993; Konradi et al., 1994; Badiani et al., 1998; Uslaner et al., 2001; 
Uslaner et al., 2001; Crombag et al., 2002; Ferguson et al., 2003; Ostrander et al., 2003; 
Uslaner et al., 2003; Uslaner et al., 2003; Ferguson et al., 2004; Samaha et al., 2004; 
Samaha et al., 2005). Cocaine and nicotine are much more effective in inducing c-fos and 
arc mRNA in diverse areas of the neocortex and subregions of the striatum when given 
rapidly (5 sec) than when given even a little more slowly (25-100 sec) (Samaha et al., 
2004; Samaha et al., 2005). This expression in subregions of the striatum is thought to 
reflect increased synaptic input from distinct and topographically arranged synaptic 
targets (Webster, 1961; McGeorge and Faull, 1989; Berendse et al., 1992; Willuhn et al., 
2003).  
However, the striatum is not a heterogeneous structure, and previous studies 
examining the effect of rate of drug administration on IEG expression have not taken this 
into consideration. In addition to differences in regional innervation, the striatum is also 
organized into biochemically distinct striosome (―patch‖) and matrix subcompartments 
(Pert et al., 1976; Graybiel and Ragsdale, 1978; Herkenham and Pert, 1981). Neurons in 
these subcompartments differ in their development (van der Kooy and Fishell, 1987; 
Song and Harlan, 1994; Heimer et al., 1997), express different proteins (Graybiel and 
Ragsdale, 1978; Graybiel et al., 1981; Herkenham and Pert, 1981; Gerfen, 1985), 
maintain partially segregated afferent inputs and efferent projections (Gerfen, 1984, 
1989), and have distinct neurophysiological characteristics (Miura et al., 2007). 
Behavioral studies have extended the idea that striosomes represent distinct functional 
units in the dorsal striatum. For example, electrical self stimulation of the striosome 
compartment is more reinforcing than stimulation in the matrix compartment (White and 
Hiroi, 1998), and animals with targeted striosomal ablations exhibit task-specific 
performance deficits (Lawhorn et al., 2009). Furthermore, it has been reported that 
animals behaviorally sensitized to cocaine as a result of repeated exposure have greater 
Fos protein expression in the patch subcompartment relative to the matrix, when 
compared to the pattern induced by an acute injection (Graybiel et al., 1990; Moratalla et 
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al., 1996; Canales and Graybiel, 2000; Canales et al., 2002). Thus, expression of c-fos 
mRNA and its protein product Fos preferentially in the striosome or matrix compartment 
is thought to reflect biochemical activation of functionally distinct populations of neurons 
(Donoghue and Herkenham, 1986; White, 1989; Gerfen, 1992; Eblen and Graybiel, 1995; 
Flaherty and Graybiel, 1995; White and Hiroi, 1998; Brown et al., 1999; Canales and 
Graybiel, 2000; Brown et al., 2002; Canales, 2005).  
Given that the rapid delivery of cocaine is more effective in producing 
psychomotor sensitization, and also is more effective in inducing c-fos mRNA in various 
striatal subregions (Samaha et al., 2004), we hypothesized that variation in the rate of 
cocaine delivery may influence IEG expression in the patch compartment to a greater 
extent than the matrix. The purpose of this experiment was to test this hypothesis. In 
addition, in this experiment we quantified the influence of rate of cocaine infusion on the 
number of cells positive for Fos protein (in previous studies we quantified only c-fos 
mRNA). This may be an important variable because post-transcriptional regulation of c-
fos mRNA may alter the amount of Fos protein (Rahmsdorf et al., 1987) in striatal MSNs 
containing the dopamine D1 receptor. This has been reported to be required for both 
cocaine-induced psychomotor sensitization and associated biochemical and structural 
changes in dendrites on MSNs in the dorsal and ventral striatum (Zhang et al., 2006; Xu, 
2008).  
Materials and Methods 
Subjects and Housing 
A total of 29 male Sprague Dawley rats (Harlan, IN) weighing between 225 – 250 
g upon arrival were used in this experiment. Prior to the start of the experiment, rats were 
individually housed in a climate-controlled animal colony maintained on a 14/10 
light/dark cycle (lights on at 0800), with food and water available ad libitum. Rats were 
given a minimum of 5 days to habituate to the animal colony. For the duration of the 
experiment, animals were housed individually in test chambers in a separate testing 
facility under the same housing conditions. To minimize the effects of extraneous noise 
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in the room, a room-wide white noise generator set to 70 dB was on continuously in the 
testing facility to mask other sounds. All procedures were approved by the University of 
Michigan Committee on the Use and Care of Animals (UCUCA). 
Catheter Construction and Surgical Procedures 
Chronically indwelling jugular catheters were placed in rats using a procedure 
similar to that described elsewhere (Weeks and Davis, 1964; Weeks, 1972; Crombag et 
al., 1996; Samaha et al., 2002). Briefly, catheters were constructed from SILASTIC® 
tubing (0.51 mm inner diameter, 0.94 mm outer diameter; Dow-Corning, Midland, MI), 
secured by polyolefin heat shrink tubing (Alpha Wire Company, Elizabeth, NJ) to a 
backport constructed from a 22 gauge, 11 mm cannula (Plastics One, Roanoke, VA) bent 
to a ninety degree angle. The cannula was supported by a 1 cm length of a trimmed 200 
µL pipette tip, and secured to a 3 cm diameter circular 250 micron mesh (Small Parts, 
Miramar, FL) by dental cement (Bosworth, Skokie, IL). While not in use, catheters were 
capped with obdurators. All catheters had a dead volume of 24-26 µL.  
Rats were anesthetized with ketamine/xylazine (100 mg/kg and 10 mg/kg, 
intraperitoneally, IP). The backport was secured between the animal‘s shoulder blades, 
while the silicon end of the catheter was inserted into the left or right external jugular 
vein. Catheters were then filled with 0.1 mL solution of 10 mg/mL gentamicin sulfate 
(Vedco, St. Joseph, MO) in 0.9% sterile bacteriostatic saline to minimize infections and 
catheter occlusions.  
Animals were allowed to recover for a minimum 4 days. Starting the day after the 
surgery, catheters were flushed manually once per day with 0.2 mL of the gentamicin 
solution. Every 5 days animals received an i.v. infusion of 0.2 mL sodium thiopental 
solution (20 mg/mL, dissolved in sterile water, Hospira, Lake Forest, IL) to assess 
catheter patency. Animals that did not become ataxic within 5-10 seconds were removed 




Test chambers were the same as those described previously (Samaha et al., 2002). 
Briefly, test chambers consisted of red plastic buckets 25 cm in diameter and 36 cm in 
height, with corncob bedding on the floor. Each test chamber was equipped with a 
photocell rotometer which measured the number of quarter turns in each direction 
(McFarlane et al., 1992). Prior to a session, each rat was tethered to a 22 gauge liquid 
swivel (Instech Solomon, Plymouth Meeting, PA) fixed to a counter-balanced arm via a 
homemade spring, which allowed the animals to move freely in the test chamber. A 
length of Tygon microbore tubing serving as the infusion line was inserted through the 
spring and attached to the catheter. A second length of Tygon tubing attached the distal 
end of the swivel to a 1.0 mL syringe, which was mounted on a programmable Harvard 
Apparatus pump (Holliston, MA). The pump was calibrated to each individual swivel and 
line apparatus so that the pump delivered a volume of 10 µL over 5 (120 µL/min), 25 (24 
µL/min), or 100 (6 µL/min) seconds. 
Groups and Procedures 
At the start of the experiment, rats were transported from the animal colony to the 
testing facility and individually placed into the test chambers, where they lived for the 
duration of the experiment. After one day of acclimatization, all rats underwent infusion 
habituation sessions for the next three days. Once per day, rats were attached to the 
infusion apparatus and infused with 10 µL of saline over 5, 25 or 100 seconds. Over the 
course of habituation sessions, all rats received each infusion rate once in a randomized 
order. Rats remained tethered to the infusion apparatus for 2 hours post-infusion, and 
then were disconnected.  
On Day 4, the infusion apparatus was prepared for a 2.0 mg/kg cocaine or saline 
infusion in the same manner as previously reported (Samaha et al., 2004). Once animals 
were attached to the infusion apparatus, rats were left undisturbed for 40 minutes to 
establish baseline motor activity. Rats were then infused with 10 µL of 2.0 mg/kg cocaine 
over 5 (n=8), 25 (n=6), 100 seconds (n=8), or saline over 5 seconds (n=7), and locomotor 
activity (quarter turns) was recorded. To allow for sufficient time for transcardial 
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perfusion at the end of the experiment, infusions were staggered 40 minutes apart. After 
the infusion the animal remained tethered to the infusion apparatus for 2 hours.  
Two hours after the injection, animals were disconnected and taken to an 
adjoining room and tested for catheter patency with sodium thiopental. Animals with 
patent catheters were immediately anesthetized with sodium pentobarbital (390 mg/kg, 
i.p., Vortech, Dearborn, MI), and perfused transcardially with 500 mL ice cold perfusion 
rinse (73 mM sucrose, 18 mM procaine hydrochloride, 139 mM sodium chloride in 0.1 M 
sodium phosphate buffer (SPB), pH 7.4), followed by 250 mL ice cold paraformaldehyde 
rinse (4% (W/V) paraformaldehyde dissolved in 0.1 M SPB buffer with 73 mM sucrose, 
pH 7.4). Brains were removed and placed in paraformaldehyde rinse overnight at 4 
degrees Celsius, and then transferred to 30% (W/V) sucrose for 3 days. Brains were 
coronally sectioned to a 40 µm thickness with a freezing microtome. Series of sections 
were collected 120 µm apart. Sections processed for immunohistochemistry within 2 
days were stored in 0.1 M SPB, otherwise sections were stored at -20 Celsius in liquid 
cryoprotectant. 
Immunohistochemistry 
Sections were processed for Fos and Mu opioid receptor protein 
immunofluorescence in a similar manner to Reynolds and Berridge (2008). Mu opioid 
immunoreactivity provides a robust marker for patch compartments (Harlan and Garcia, 
1998). Sections were washed in 0.1 M SPB containing 0.2% (V/V) Triton-X with gentle 
agitation for 30 minutes, and then pre-blocked for 30 minutes in a 5% (V/V) Normal 
Donkey Serum (NDS) solution. Sections were then incubated overnight with a primary 
antibody solution containing 1:500 goat polyclonal antibody raised against the N-
terminus of human Fos (sc-52-G, Santa Cruz, Santa Cruz, CA) and 1:1000 rabbit 
polyclonal antibody raised against the C-terminus of the rat Mu opioid receptor 1 
(ab10275, Abcam, Cambridge, MA). After washing in 0.1 M SPB for 30 minutes, 
sections were pre-blocked in a solution containing 5% NDS and 5% (V/V) Image-iT FX 
signal enhancer (Invitrogen, Eugene, OR) for 30 minutes. Sections were subsequently 
incubated for 2 hours in a solution containing 1:250 donkey anti-goat AlexaFlor 488 
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antibody and 1:250 donkey anti-rabbit AlexaFlor 594 antibody (Invitrogen, Carlsbad, 
CA) and 5% signal enhancer. Next, sections were washed in SPB buffer and mounted, 
air-dried, and coverslipped with Prolong Gold anti-fade reagent (Invitrogen, Eugene, 
OR). Control tissue stained with only secondary antibodies revealed little or no 
unspecific binding.  
Visualization  
Sections were visualized at 100x total magnification with a Leica DMRx 
(Wetzlar, Germany) microscope with a Leica HBO-100 fluorescent light source coupled 
to a Sony DXC-970 MD (Tokyo, Japan) camera. AlexaFlor 488 was fluoresced using a 
Leica L5 bandpass filter cube, and AlexaFlor 594 was fluoresced using a N3 bandpass 
filter cube. The same section and region was imaged for Fos and Mu opioid receptor 
immunoreactivity. Separate Fos and Mu opioid images were captured as LZW lossless 
compression TIFF files to minimize image compression artifacts in dark-field areas of the 
image and were analyzed using the MCID Elite (Cambridge, UK) software package. 
Figures 2.2-2.4 provide sample images of both Fos and Mu opioid receptor staining in the 
dorsal and ventral striatum.  
Sampling Areas 
In all areas of the brain examined, data from the left and right hemisphere were 
summed together. All brain regions were identified by Paxinos and Watson (4
th
 Edition, 
1998). The dorsal striatum was sampled at +1.7 mm, +1.2 mm, and +0.0 mm from 
bregma. Fig. 2.2 illustrates the areas of the dorsal striatum sampled. At +1.7 mm from 
bregma, a sampling area of 0.508 mm
2 
(725 µm x 700 µm) per hemisphere was used to 
account for the smaller area of the striatum. For the more caudal sections, a sampling area 
of 1.08 mm
2
 (1200 µm x 900 µm) per hemisphere was used. The nucleus accumbens 
(NAc) shell and core were sampled at +2.0 mm from bregma. Fig. 2.3 illustrates areas of 
the NAc sampled. An elliptical sampling area of 300x900 µm
2 
was used to sample the 
shell, and a smaller sampling area of 300x450 µm
2 
was used for the core. To better follow 
the contours of the shell and the core, sampling ellipses were angled. The infralimbic (IL) 
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cortex was chosen as the cortical sampling area because this area showed the greatest 
influence of rate of cocaine infusion on c-fos mRNA expression (Samaha et al., 2004). 
The IL was sampled at 2.0 mm from bregma, with the lateral terminus of the forceps 
minor corpus callosum serving as the main morphological landmark for the location of 
the IL. Fig. 2.3 illustrates areas of the IL sampled. The IL was sampled using a circular 
sampling area 800 µm in diameter.  
Quantification 
For Fos nuclei quantification, Fos images were optimized for counting by 
applying the ―Target Accentuate‖ filter available within MCID Elite with a matrix setting 
of 9x9, using a method previously reported by Vanderschuren and colleagues (2002). 
Briefly, the filter increases contrast between areas of differing intensity value, while 
decreasing the contrast between areas of similar intensity. A higher matrix value applies a 
more aggressive transformation to the target image. Using the ―Autoscan Utility,‖ a 
maximum of 5 Fos positive cells were visually identified in each image by the 
experimenter and sampled for hue and intensity values using a 4 micron diameter 
sampling circle. The average value provided the threshold for identifying and quantifying 
Fos positive nuclei in the image. In addition, a ―Target selection criteria‖ optimized to 
reduce the incidence of image artifacts contributing to the final count was used. Targets 
thus identified by the ―Autoscan Utility‖ were then overlaid on the original unaltered Fos 
image and visually inspected to ensure fidelity in quantification and to minimize the 
contribution of artifacts towards the final cell count. In cases where no Fos positive 
nuclei could be identified in the section, Fos-positive nuclei from the cortex immediately 
adjacent to the striatum were used to set the target threshold. 
For patch identification, areas with high Mu opioid receptor expression were 
visually identified by the experimenter and manually selected using the ―Autoscan B‖ 
utility. The number of cells within each patch, as well as the area of each patch in each 
sampling area, was recorded. 
To calculate the patch versus matrix ratio, the Index of Striosome to Matrix 
Predominance (ISMP) (Canales and Graybiel, 2000) was determined by calculating the 
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ratio between the density of Fos-positive neurons in the patch and the density of Fos-
positive neurons in the matrix. 
All quantification was done by trained raters blind to the experimental condition 
of the animal. 
Statistics   
Fos counts and ISMP ratios were compared using analyses of variance and where 
appropriate post-hoc comparisons were made using Fishers LSD tests. 
Results 
Acute Locomotor Behavior 
Fig. 2.1 shows the number of quarter turns in the first 12 minutes following a 
single i.v. injection of 2.0 mg/kg cocaine delivered over 5, 25, or 100 sec (control saline 
administered over 5 sec). This time period captures the duration of the behavioral effect. 
There was a main effect of treatment (F(3,28)=5.031, p<0.007), and post-hoc tests 
revealed that the effect arose because the drug treatments increased locomotor activity 
relative to saline (saline vs. 5 sec p<0.007, saline vs. 25 sec p<0.002, saline vs. 100 sec 
p<0.038). There were, however, no significant differences in the acute psychomotor 
activating effects of cocaine as a function of rate of infusion, consistent with our previous 
studies (Samaha et al., 2002; Samaha et al., 2004). 
Dorsal Striatum (Total Fos Positive Cells) 
Figs. 2.2-2.3 show sample images to illustrate the labeling and the location of the 
regions sampled. Fig. 2.5 shows the total number of Fos positive nuclei per mm
2
 in four 
subregions of the dorsal striatum (dorsal medial, DM; dorsal lateral, DL; ventral lateral, 
VL; ventral medial, VM) across three rostrocaudal levels (+1.7 mm, 1.2 mm, +0.0 mm 
from bregma) in four groups of rats (those who received a single acute i.v. infusion of 2.0 
mg/kg cocaine over 5, 25, or 100 sec, or saline over 5 sec).  
In the DM subregion, cocaine increased the number of Fos positive cells, relative 
to the saline control group, at all rates of infusion. An overall two-way ANOVA 
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analyzing the effect of group and rostrocaudal level on the number of Fos nuclei resulted 
in a main effect of group (F(3,87)=23.847 p<0.001) and rostrocaudal level (F(2,87)=4.10 
p<0.001). The interaction trended towards significance (F(6,87)=2.073 p=0.065). Similar 
to effects of cocaine on c-fos mRNA, cocaine increased the number of Fos positive cells 
in the caudal striatum more than in the rostral striatum. Pairwise comparisons showed 
that cocaine significantly increased the number of Fos positive cells in all groups (saline 
vs. 5 sec, p<0.001; vs. 25 sec, p<0.001; vs.100 sec, p<0.016). However, when delivered 
over 5 sec, cocaine increased the number of Fos positive cells to a significantly greater 
extent than when it was delivered over either 25 or 100 sec (p‘s<0.001). The 25 sec and 
100 sec groups did not differ from one another (p=0.137).  
In the DL subregion, a two-way ANOVA resulted in a main effect of group 
(F(3,87)=12.114 p<0.001) and rostrocaudal level (F(3.387) p<0.039). The interaction was 
not significant (F(6,87)=0.510). As in the DM striatum, cocaine induced more Fos 
positive cells caudally. In this region, only when cocaine was delivered over 5 sec did it 
significantly increase the number of Fos positive cells (saline vs. 5 sec, p<0.001; vs. 25 
sec, p=0.203; vs. 100sec, p=0.109), and the 5 sec group differed significantly from both 
the 25 sec and 100 sec groups (p‘s<0.001)  
In the VL, there was a main effect of group (F(3,87)=5.353 p<0.003), but no 
effect of rostrocaudal level (F(2,87)=0.778 p=0.463; interaction, F(6,87)=0.508 p=0.800). 
Only when cocaine was delivered over 5 sec did it significantly increase the number of 
Fos positive cells (p<0.001).  
In the VM, a two-way ANOVA analysis resulted in a main effect of group 
(F(3,87)=22.804 p<0.001) and rostrocaudal level (F(2,87)=3.932 p<0.024, but no 
interaction F(6,87)=1.005 p=0.427). All groups given cocaine had significantly more Fos 
positive cells than the group given saline (saline vs. 5 sec p<0.001; vs. 25 sec p<0.001; 
vs. 100 sec p<0.004). However, when delivered over 5 sec, cocaine produced 
significantly more Fos positive cells than when it was delivered over either 25 sec or 100 
sec (p‘s<0.001), and the latter two groups did not differ from one another (p=0.373). In 
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VM striatum, the number of Fos positive cells was lower at the level 1.2 mm from 
bregma than more rostrally or caudally. 
Nucleus Accumbens and Infralimbic Cortex  
Fig. 2.6 shows the number of Fos positive nuclei per mm
2 
in the nucleus 
accumbens core (NAcc), shell (NAcs), and the infralimbic (IL) cortex sampled at +2.0 
mm from bregma, as a function of treatment condition. In both the NAcs and NAcc, a 
one-way ANOVA resulted in significant effect of treatment (NAcs, F(3,29)=10.514, 
p<0.001; NAcs, F(3,29)=9.096 p<0.001). Post-hoc tests revealed that when compared to 
saline, all drug treatments produced an increase in the number of Fos positive cells 
(NAcs, saline vs. 5 sec p<0.001; vs. 25 sec, p<0.006; vs. 100 sec p<0.011; NAcc, saline 
vs. 5 sec, p<0.001; vs. 25 sec p<0.025; vs. 100 sec, p<0.030). However, when cocaine 
was delivered over 5 sec it induced a significantly greater number of Fos positive cells 
than when delivered over either 25 or 100 sec in both subregions of the accumbens (all 
p‘s<0.034), and the 25 and 100 sec groups did not differ from one another. 
In the IL, there was a main effect of group (F(3,29)=3.116 p<0.042), and all rates 
of infusion increased the number of Fos positive cells, but there was no effect of rate of 
infusion.  
The results presented above are consistent with previous studies regarding the 
effects of rate of cocaine infusion on the induction of c-fos mRNA in the dorsal and 
ventral striatum (Samaha et al., 2004). The results also extend these findings by showing 
that rate of cocaine infusion has a similar effect on the number of cells positive for Fos 
protein. However, the major purpose of this experiment was to determine if rate of 
infusion had a differential effect on the number of Fos positive cells in the patch 
(striosome) vs. matrix subcompartments in the dorsal striatum (Fig. 2.4), and those results 
are shown in Fig. 2.7.  
Dorsal Striatum (Patch vs. Matrix) 
Fig. 2.7 (Panel a) shows the number of Fos positive nuclei in the patch or matrix 
subcompartments of either the dorsal medial or dorsal lateral striatum. The Fos counts 
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were averaged across all bregma levels sampled (+1.7 mm, +1.2 mm, +0.0 mm), as this 
factor did not influence the results. There was a large effect of rate of infusion on the 
ability of cocaine to increase the number of Fos positive cells in both the patch and 
matrix compartments (Group effect: DM – F(3,58)=27.11; DL – F(23,58)=10.29, both 
p‘s<0.0001). However, the effect of rate of infusion was clearly the same in both the 
patch and the matrix compartments (effect of compartment non-significant: DM – 
F(1,58)=0.03 p=0.8567; DL – F(1,58)=0.37 p=0.5443; interaction DM – F(3,58)=0.19 
p=9.742; DL – F(3.58)=9.021). Panel b shows the same data expressed as the Index of 
Striosomal Matrix Predominance (ISMP), and one-way ANOVAs comparing ISMP 
across groups resulted in no significant group differences (DM – F(3,29)=2.342 p=0.094; 
DL – F(3,29)=0.274, p=0.844).  
Discussion 
When cocaine is injected rapidly it is more effective in producing psychomotor 
sensitization and inducing c-fos mRNA in the dorsal and ventral striatum (Samaha et al., 
2004). Here we quantified the influence of rate of cocaine delivery on the number of cells 
positive for Fos protein in the striatum, and also tested the hypothesis that the rapid 
delivery of cocaine would induce greater Fos immunoreactivity preferentially in the patch 
subcompartment. The results strongly support and extend our previous mRNA findings. 
Cocaine delivered i.v. over 5 sec increased the number of Fos positive cells in both the 
dorsal and ventral striatum to a much greater extent than when it was delivered over 25-
100 sec. However, the effect of rate of cocaine delivery was equally evident in the patch 
and matrix subcompartments of the dorsal striatum. Therefore, even though there are 
many differences between the patch and matrix subcompartments (see Introduction) it 
appears that the influence of rate of cocaine delivery on IEG expression in the dorsal 
striatum is widespread, and not localized to either the patch or matrix subcompartments. 
Cocaine is an indirect agonist of monoamine neurotransmitters, primarily binding 
to presynaptic proteins including those that transport dopamine, serotonin and 
norepinephrine (Heikkila et al., 1975; Ritz et al., 1987; Giros and Caron, 1993). The 
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blockade of the dopamine transporter by cocaine in particular increases synaptic 
concentrations of dopamine and other monoamines. The range of infusion rates used in 
this study (5 – 90 sec) produces the same peak concentration of cocaine in the brain (Pan 
et al., 1991; Samaha et al., 2002), produces similar peak concentrations of dopamine in 
the striatum (Ferrario et al., 2008), and are equally effective in producing acute 
psychomotor activation (present data; Samaha et al, 2004). Nevertheless, there was a 
large effect of rate of cocaine delivery on its ability to increase the number of Fos 
positive cells in the striatum. This suggests that small differences in how rapidly cocaine 
reaches the brain, and presumably small differences in the temporal dynamics of 
transporter blockade, can have large effects on downstream intracellular molecular 
cascades, including those responsible for IEG expression. 
Fos expression was utilized in this study as a biochemical marker for activation of 
intracellular signaling cascades (Sagar et al., 1988; Sheng and Greenberg, 1990; Morgan 
and Curran, 1991; Harlan and Garcia, 1998), but its native role inside neurons is as a 
constituent in a transcription factor complex (Activation protein-1 (AP-1)) (Sheng and 
Greenberg, 1990; Hughes and Dragunow, 1995) capable of inducing the expression of 
downstream genes that contain AP-1 binding domains (Morgan and Curran, 1991). In the 
striatum, increased Fos expression produced by an acute injection of cocaine is dependent 
primarily on the D1 dopamine receptor (Graybiel et al., 1990; Young et al., 1991; 
Moratalla et al., 1996), and therefore expression of Fos in D1 dopamine receptor 
expressing striatal neurons is thought to initiate a gene expression cascade contributing 
towards a wide range of enduring neurobiological changes, including changes associated 
with psychomotor sensitization (Nestler, 2001). Consistent with this idea, transgenic mice 
with targeted deletions of Fos in D1 receptor expressing striatal neurons exhibit 
attenuated psychomotor sensitization compared to wild-type controls, and also fail to 
show associated structural modification in dendrites on medium spiny neurons (Zhang et 
al., 2006; Xu, 2008). Using gene microarrays, over 100 genes have been found to be 
upregulated by chronic cocaine treatment in wildtype mice compared to D1 receptor 
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deficient mice, including those implicated in enduring structural changes in neurons 
(Zhang et al., 2005).  
It should be noted that although the acute effects of faster rates of cocaine 
infusion on Fos expression are thought to be mediated by D1 receptor expressing 
neurons, the selectivity for D1 mediated Fos expression to cocaine is heavily modulated 
by the environmental context in which the drug was delivered (Badiani and Robinson, 
2004). Drug induced Fos expression in the mesocorticolimbic system and psychomotor 
sensitization is enhanced when given in a novel environment distinct from an animal‘s 
homecage (Badiani et al., 1995; Badiani et al., 1995; Badiani et al., 1998; Browman et 
al., 1998; Day et al., 2001; Uslaner et al., 2001). Notably, the pattern of Fos expression 
between ―home‖ and ―novel‖ drug experienced groups are distinct along the rostrocaudal 
axis of the caudate (Badiani et al., 1998; Uslaner et al., 2001; Ostrander et al., 2003), and 
activate a different subpopulation of MSNs expressing the D2 receptor and enkephalin 
(Enk) (Badiani et al., 1999), possibly through corticostriatal glutamate (Ferguson et al., 
2003). While faster rates of infusion were found to equally induce c-fos mRNA 
expression in both Enk+ and Enk- neurons (Samaha et al., 2004), the results of this study 
leave open the possibility that D2 expression may play a role in the induction of Fos 
protein as a result of faster rates of infusion.   
The brain circuits strongly influenced by faster rates of drug infusion include the 
mesocorticolimbic circuits, which consist of parallel cortico-subcortical loops (Alheid 
and Heimer, 1988; Heimer and Van Hoesen, 2006). These systems are normally involved 
with reward processes such as incentive motivation (Berridge and Robinson, 1998; 
Berridge, 2004) and reward associated learning (Yin et al., 2004; Ostlund and Balleine, 
2005; Yin et al., 2008); dopamine projections from neurons in the substantia nigra pars 
reticulata and ventral tegmental area to these regions have been strongly implicated in 
mediating the reinforcing and other effects of cocaine (Roberts et al., 1977; Roberts et al., 
1980; Ritz et al., 1987; Wise and Bozarth, 1987; Di Chiara and Imperato, 1988; Camp et 
al., 1994). Furthermore, changes in these same systems as a result of exposure to drugs of 
abuse are thought to contribute to the development of addiction (Robinson and Berridge, 
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1993; Hyman and Malenka, 2001; Robinson and Berridge, 2003). Thus, the fact that 
rapidly delivered cocaine preferentially engages this circuitry may be one reason why 
drugs or formulations that enter the brain rapidly are more likely to produce addiction. 
In summary, a diverse variety of long-term, persistent neuroadaptations in the 
mesocorticolimbic circuit can be mediated by increased striatal Fos expression. Since 
faster rates of infusions preferentially induce greater Fos expression and induce 
behavioral sensitization (Samaha et al., 2002; Samaha et al., 2004), faster rates of cocaine 
infusion should also have a strong impact on drug-taking behavior in the rat, especially 
under conditions that produce addition-like symptoms. This question is explored in the 





Fig. 2.1 Mean (± SEM) locomotor activity (number of quarter turns) during the first 12 
minutes after a single acute i.v. injection of 2.0 mg/kg cocaine delivered over 5, 25 or 100 
sec, or saline delivered over 5 sec.  
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Fig. 2.2 Example images showing Fos positive neurons (labeled in green) in two 
subregions of the dorsal striatum across two rostrocaudal levels of bregma 2 hours after 
an acute infusion of 2.0 mg/kg cocaine given over 5 – 100 sec or saline given over 5 sec. 
Scale bar indicates 100 microns. Areas sampled in the experiment relative to other 








Fig. 2.3 Example images of Fos positive neurons (labeled in green) in the nucleus 
accumbens (NAc) and infralimbic cortex at 2.0 mm from bregma two hours after an acute 
infusion of 2.0 mg/kg cocaine given over 5 – 100 sec or saline over 5 sec. Scale bar 
indicates 100 microns. Areas sampled within the nucleus accumbens (core and shell 







Fig. 2.4 Example images of the patch (identified as areas of high Mu opioid receptor 
immunoreactivity labeled in red) and matrix subcompartments where the distribution of 
Fos positive nuclei (labeled in green) was quantified in the dorsal medial and dorsal 
lateral subregions of the dorsal striatum +1.2 mm from bregma. Scale bar indicates 100 
µm. Areas sampled in the experiment are indicated in the diagram on the left. Areas 
sampled in the experiment relative to other anatomical features are schematically 







Fig. 2.5 The mean (±SEM) number of Fos positive nuclei per mm
2 
in four subregions of 
the dorsal striatum across three rostrocaudal levels (+1.7, +1.2, +0.0mm from bregma) in 







Fig. 2.6 The mean (± SEM) number of Fos positive nuclei per mm
2
 in the nucleus 
accumbens shell and core subdivisions, and the infralimbic cortex (IL) sampled at 
+2.0mm from bregma, in rats given an acute infusion of saline or cocaine delivered over 







Fig. 2.7 Panel a: The mean (± SEM) number of Fos positive nuclei in the patch (P) or 
matrix (M) subcompartments of either the dorsal medial (DM) or dorsal lateral (DL) 
striatum in rats given saline (S), or an acute infusion of cocaine delivered over 5, 25 or 
100 sec. The number of Fos positive cells was averaged across all rostrocaudal levels 
sampled (+1.7 mm, +1.2 mm, +0.0mm), as this factor did not influence the results. Panel 
b: The same data as in Panel a, but expressed as the mean (+ SEM) Index of Striasomal 
Matrix Predominance (ISMP). A value of 1 indicates no difference between the patch 









 THE INFLUENCE OF RATE OF INTRAVENOUS COCAINE DELIVERY ON 
SELF-ADMINISTRATION BEHAVIOR UNDER LIMITED VS. EXTENDED 
ACCESS CONDITIONS 
Introduction 
Cocaine use and its ability to foster addiction is a persistent and widespread 
public health problem, therefore there is considerable interest in understanding the factors 
that influence liability to addiction. One such factor is how quickly cocaine reaches the 
brain. The rate at which a drug reaches the brain largely depends on its formulation and 
route of administration into the body (Javaid et al., 1978; Javaid et al., 1983; Jones, 1990; 
Foltin and Fischman, 1991; Hatsukami and Fischman, 1996), and there is strong evidence 
that how rapidly cocaine reaches the brain is a major factor contributing to its abuse 
liability (Jones, 1990; Gossop et al., 1992, 1994; Hatsukami and Fischman, 1996; Ferri 
and Gossop, 1999). For example, subjects who initiate their use through smoking the 
rapidly absorbed ―crack‖ cocaine base, rather than insufflating (―snorting‖) the more 
slowly absorbed cocaine hydrochloride, are more likely to develop symptoms of 
addiction or clinical dependence (Gorelick, 1998; Chen and Anthony, 2004; O'Brien and 
Anthony, 2005).  
The rapid delivery of cocaine produces greater euphorigenic effects than slower 
delivery (Resnick et al., 1977; Fischman, 1984; Volkow et al., 2000; Abreu et al., 2001; 
Nelson et al., 2006), and this is a common explanation for faster rates of cocaine 
administration facilitating the transition to addiction (Gorelick, 1998). Consistent with 
this, there is some evidence from animal studies that increasing the rate of drug infusion 
increases the reinforcing properties of cocaine (Balster and Schuster, 1973; Kato et al., 
1987; Panlilio et al., 1998; Woolverton and Wang, 2004). However, in some of these 
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studies, effects were seen only when rates of infusion differed to such an extent that they 
would result in different brain levels of the drug. Indeed, in rats, cocaine infused between 
5 and 100 sec produced the same peak brain levels of cocaine, and there was no effect on 
self-administration behavior when animals were given limited access to the drug over a 
range of different schedules of reinforcement (Pickens et al., 1969; Crombag et al., 2008). 
Although rats can learn to discriminate and preferentially select faster rates of cocaine 
delivery when given a choice (Schindler et al., 2009), the evidence that it influences the 
reinforcing effects of cocaine is not very compelling. 
However, in the preceding chapter, I reported that how rapidly cocaine reaches 
the brain has a large effect on its neurobiological impact on the mesocorticolimbic 
system. When cocaine reaches the brain rapidly it engages more cells and circuits than 
when it reaches the brain at a slightly slower rate. These neurobiological changes 
produced by faster rates of drug delivery may contribute to the transition from casual use 
to addiction (Samaha and Robinson, 2005). If so, faster rates of infusion should also 
strongly influence drug-taking and drug-seeking behavior in the rat, especially under 
conditions that can produce addiction-like symptoms. 
Previous studies on the effects of rate of drug delivery on self-administration 
behavior mentioned above used relatively limited access self-administration procedures, 
and there are now a number of reports that extended access to cocaine is required for the 
development of addiction-like symptoms. When given extended access to cocaine, either 
by increasing the amount of time it is available each day or by making it available for 
months, rats begin to exhibit changes in behavior resembling the symptoms of human 
addicts, including a escalation of intake (Ahmed and Koob, 1998, 1999; Ahmed et al., 
2002), resistance to drug related punishment (Deroche-Gamonet et al., 2004; 
Vanderschuren and Everitt, 2004; Pelloux et al., 2007; Belin et al., 2008), and an 
increased motivation for drug (Deroche-Gamonet et al., 2004; Ben-Shahar et al., 2008). 
Consistent with this, rats with a fairly extensive history of self-administration under a 
progressive ratio schedule of reinforcement gradually increase their breakpoints across 
successive sessions, but only if their drug is delivered rapidly (Liu et al., 2005). I 
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hypothesized, therefore, if the rate of cocaine delivery to the brain influences the 
propensity to addiction, it may influence self-administration behavior only if rats are 
given extended access to cocaine – even if the same rate has no effect on its reinforcing 
properties under limited access conditions. The purpose of this study was to test this 
hypothesis. 
Material and Methods 
Subjects and Housing 
Male Wistar rats (Harlan, IN) weighing between 225 – 250 g upon arrival were 
used in this experiment. Rats were individually housed in a climate-controlled animal 
colony maintained on a 14:10 light/dark cycle (lights on at 0800), with food and water 
available ad libitum. Rats were given a minimum of 5 days to habituate to the animal 
colony. All procedures were approved by the University of Michigan Committee on the 
Use and Care of Animals (UCUCA).  
Animals were included in the experiment only if they acquired and maintained 
stable self-administration behavior and completed all phases of testing. A total of 46 
animals completed the study. Animals were removed from the experiment mainly 
because they did not acquire self-administration behavior or their catheters lost patency 
before completing the experiment. This did not impact one group more than the others. 
Apparatus 
Behavioral training and testing occurred in operant chambers located in a 
different room than the animal‘s home cage. The chambers measured 22 x 18 x 13 cm 
(Med-Associates, VT), and were located inside larger sound-attenuating cabinets, which 
were continuously ventilated by a fan providing background noise. Each operant chamber 
was outfitted with two illuminated infrared nose-poke ports surrounding a centrally 
located pellet dispenser and pellet cup, and a red houselight was positioned on the 
opposite wall. The floor of the chamber consisted of a grid floor with corncob bedding 
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below the grids, which was replaced daily. Chambers were controlled by a PC computer 
(Intel Core Duo E4500) running Med-PC Version IV. 
Each operant chamber was equipped with an infusion apparatus consisting of a 10 
mL syringe installed in a PHM-100 pump (Med-Associates, VT) attached via a length of 
Tygon microbore tubing to an Instech-Solomon liquid swivel (Plymouth Meeting, PA) 
mounted on a counterbalanced arm. On training and test days, animal‘s catheters were 
attached to the liquid swivel via another length of PE tubing inserted within a homemade 
spring. Rates of drug delivery were controlled by installing motors (Model R-DE, Med-
Associates, VT) capable of delivering a 50 µL infusion over 4.5 sec (2 RPM, 0.661 
mL/min), 45.4 sec (0.2 RPM, 0.066 mL/min), and 90.8 sec (0.1 RPM, 0.033 mL/min). In 
referring to these groups, the rates are ―rounded‖ and I will refer to groups receiving 
cocaine over 5, 45 or 90 sec. Prior to each use, the apparatus was flushed with a 20% 
ethanol aqueous solution (V/V) to ensure adequate liquid flow through the swivel and 
lines. Additionally, every 20 days the infusion efflux delivered by the apparatus was 
volumetrically measured.  
The rates of infusion used here were chosen because they represent a range 
similar to what addicts report using (Zernig et al., 2003), captures the variation between 
snorting and smoking cocaine (Jones, 1990), and a range that influences its subjective 
effects in humans (Abreu et al., 2001). Also, as demonstrated in the previous chapter, 
variation in cocaine delivery over this range influences the ability of cocaine to induce 
immediate early genes, even though they produce comparable peak levels of cocaine in 
the brain and the same amount of dopamine efflux in the striatum (Pan et al., 1991; 
Ferrario et al., 2008).  
Pretraining 
An illustration of the general experimental design is shown in Figure 3.1. To 
facilitate the acquisition of cocaine self-administration, rats underwent operant response 
training using a food reward prior to jugular catheterization. On the first day, rats were 
habituated to the operant chamber, and one food pellet (45 mg Banana flavored Dustless 
Precision Pellets, Bio-Serv, NJ) was delivered into the pellet cup at a pseudo-random 
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interval approximately every 30 sec during a 30 min session. On the next three days, rats 
were trained to nosepoke for food reward using a continuous schedule of reinforcement 
(FR1). At the start of session, the houselight turned on and the ―active‖ nosepoke port 
was illuminated for 20 sec. Responses in the active port resulted in the delivery of one 
pellet. Responses in the ―inactive‖ port were recorded but did not have any programmed 
consequences. Rats were then transitioned to a fixed ratio 2 (FR2) schedule for a 
minimum of three days to further aid in discrimination between the active and inactive 
nosepoke ports.  
Catheter Construction and Surgical Procedures 
Chronically indwelling jugular catheters were placed into rats using a similar 
procedure described elsewhere (Weeks and Davis, 1964; Weeks, 1972; Crombag et al., 
1996; Samaha et al., 2002). Briefly, catheters were constructed from SILASTIC® tubing 
as described in Chapter 2. While not in use, catheters were capped with obdurators. All 
catheters had a dead volume of 24-26 µL.   
Rats were anesthetized with ketamine/xylazine (100 mg/kg and 10 mg/kg, 
intraperitoneally (i.p.)). The backport was secured between the animal‘s shoulder blades, 
while the silicon end of the catheter was inserted into the left or right external jugular 
vein. Catheters were then filled with 0.1 mL solution of 10 mg/mL gentamicin sulfate 
(Vedco, St. Joseph, MO), in 0.9% sterile bacteriostatic saline to minimize infections and 
catheter occlusions.  
Animals were allowed to recover for a minimum of 4 days. Starting the day after 
the surgery, catheters were flushed manually once per day with 0.2 mL of the gentamicin 
solution. Every 7 days animals were infused intravenously with 0.2 mL sodium thiopental 
solution (20 mg/mL, dissolved in sterile water, Hospira, Lake Forest, IL) to assess 
catheter patency. Animals that did not become ataxic within 5-10 sec were removed from 




Drugs and self-administration training 
Cocaine hydrochloride (National Institutes of Drug Abuse, MD) was prepared in a 
0.9% sterile saline solution. During self-administration sessions, animals received 
infusions consisting of 0.4 mg/kg cocaine (weight of the salt) in a volume of 50 µL. The 
unit dose was adjusted every four days.  
After recovery from surgery, animals were re-acclimatized to the operant chamber 
by an additional session with an FR2 response requirement for a food pellet. The 
following day all animals began daily cocaine self-administration training sessions. All 
training sessions were one hour long, and in all training sessions all rats received 
cocaine over 5 sec. Before each session, catheters were flushed with 0.2 mL of the 
gentamicin solution, and then attached to the infusion apparatus. Upon an experimenter-
initiated command, the infusion pumps were activated to fill the dead volume of the 
catheters prior to the start of session. Once catheters were filled, the session began with 
the illumination of the houselight and a 20 sec illumination of the active nosepoke port. 
Initially, animals were trained on a continuous reinforcement schedule (FR1) receiving 
cocaine followed by an unsignaled 20 sec timeout interval, where further responses were 
recorded but had no consequences. Once animals were responding above a minimum 
training criterion (2 or more injections per session, twice as many active versus inactive 
nosepokes) for two consecutive days, the response requirement was increased to an FR2 
schedule of reinforcement. After achieving stable performance above the minimum 
training criterion at this schedule for two consecutive days, the timeout interval in 
subsequent daily sessions was lengthened from 20 sec to 45 sec, then 63 sec, and finally 
85 sec. The reason for increasing the final timeout period to 85 sec was so that in 
subsequent sessions using different rates of infusion, the total number of infusions 
possible for all subjects in all groups would remain the same. That is, regardless of 
infusion rate all rats could only take one injection every 90 sec (see Fig. 3.2).  
Influence of Rate of Infusion: Short Access (1 hr) Sessions 
After acquiring cocaine self-administration on a FR2 schedule of reinforcement 
during one hour sessions where cocaine was injected over 5 sec with an 85 sec timeout 
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interval (this is referred to as ―Baseline‖), animals were assigned to one of three groups 
that differed in rate of cocaine delivery. One group (―5 sec,‖ n=14) continued to receive 
cocaine infusions at the training rate of infusion with the same timeout interval. A second 
group (―45 sec,‖ n=18) received their infusions over 45.4 sec followed by a 45 sec 
timeout interval. The last group (―90 sec,‖ n=14) was infused with cocaine delivered over 
90.8 sec, with no timeout interval (Fig 3.2). Individual subjects were assigned in such a 
way that the mean number of infusions achieved during the last two days of baseline 
training was balanced between groups. Rats were tested for three daily sessions at their 
respective new rates during ―short access‖ (1 hr) sessions.  
Influence of Rate of Infusion: Long Access (6 hr) Sessions 
From Day 4 to Day 20 of self-administration testing, the length of each session 
for all groups was increased to six hours/day, as this procedure is reported to lead to the 
development of addiction-like symptoms (Ahmed and Koob, 1998, 1999; Ahmed et al., 
2002). Once the sessions were extended, animals began self-administration testing at 
1100 in order to reduce the influence of circadian rhythms on self-administration 
performance. Rats were removed from the study during long access sessions if they failed 
to maintain a median number of infusions greater than 2.5 and a median active/inactive 
nosepoke ratio greater than 1 throughout the experiment. 
Statistics 
Behavioral data during long access sessions was analyzed as bins comprised of 
the average of two contiguous daily sessions. Between group comparisons were analyzed 
using one-way analyses of variance (ANOVA) or two-way ANOVA, where appropriate. 
Data with repeated measures over sessions or time was analyzed using Linear Mixed 
Models analysis (LMM) using the SPSS 16 statistical package. For LMM analysis, the 
best fitting model of repeated measures covariance was determined by the lowest Akaike 
Information Criterion (AIC) score (West, 2007). Depending on the model selected, the 
degrees of freedom may have been adjusted to a non-integer value. If the LMM resulted 
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in significance, mixed model pairwise multiple comparisons of repeated measures means 
(Kowalchuk and Keselman, 2001) were used to test for group differences.  
Results 
Training  
Fig 3.3 shows the number of active and inactive nosepokes (Panel a) and cocaine 
infusions (Panel b) during training sessions where rats met the criteria for self-
administration (2 or more injections per session, twice as many active versus inactive 
nosepokes, for two consecutive days), and advanced through stages where the timeout 
interval during successive daily sessions was increased from 20, 45, 63, and finally 85 
sec. During these training sessions, all rats self-administered 0.4 mg/kg/inf cocaine 
delivered over 5 sec. As expected, a linear mixed models analysis (LMM) with repeated 
effects of training session showed that there was no effect of differing timeout intervals 
on either active nosepoking behavior (F(3,45)=1.667 p=0.187) or the number of infusions 
during these sessions (F(3,135)=1.247 p=0.295). 
Fig. 3.4 ―Baseline‖ shows the mean number of active and inactive nosepokes 
(Panel a) and cocaine infusions (Panel b) averaged over the last two training sessions 
when all rats received cocaine over 5 sec (for these data the 3 groups represent the 
animals that on the next day will receive cocaine at different rates). A two-way ANOVA 
on the number of nosepokes during the session with group (rate of infusion, ROI) and 
nosepoke type (―Active‖ or ―Inactive‖) as fixed factors showed a main effect of nosepoke 
type (F(1,84)=54.68 p<0.0001), but no effect of group (F(2,84)=2.423 p=0.095), and no 
significant group by nosepoke interaction (F(2,84)=1.028 p=0.362). A one-way ANOVA 
on the number of infusions with ROI as the factor revealed no significant difference in 
the number of infusions (Fig. 3.4b; F(2,26)=0.622 p=0.54). Thus, prior to being subjected 
to different conditions, there were no group differences in either discriminating nosepoke 
ports or number of infusions.  
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Short Access Sessions  
Figure 3.4a also shows the number of nosepokes made during three daily one hour 
(―short access,‖ ShA) sessions (ShA1-3) after rats were assigned to groups that received 
cocaine over 5, 45 or 90 sec. A LMM on the number of active nosepokes during the ShA 
sessions with ROI (group) as a fixed factor and session as a repeated measure revealed 
that there was no significant effect of group (F(2,43.8)=0.776 p=0.465), session 
(F(2,74.2)=0.198 p=0.819) or a significant interaction (F(4,74.2)=0.611 p=0.655). Figure 
3.4b shows that for number of infusions there were also no effects of group 
(F(2,44)=2.553 p=0.88), session (F(2,85)=0.407 p=0.666), or group by session 
interaction (F(4,85)=0.134 p=0.96). 
Figure 3.4c shows the number of infusions achieved by three representative 
subjects from each group during the last short access session. Subjects were chosen who 
represent the group averages. The length of the horizontal line represents the duration of 
one short access session, and each vertical line shows the time during the session the 
animal received an infusion of cocaine.  
In summary, during ShA sessions there was no significant effect of varying the 
rate of cocaine infusion on self-administration behavior, as assessed by either the number 
of active nosepokes or total infusions received during the session. This is consistent with 
our more extensive previous studies on the effect of rate of cocaine or amphetamine 
delivery on self-administration behavior under limited access conditions (Crombag et al., 
2008). 
Long Access Sessions  
Figure 3.5 shows the number of active nosepokes (Panel a) and cocaine infusions 
(Panel b) made by rats in each group after the sessions were lengthened to 6 hours/day 
(―long access,‖ LgA). LgA session data were analyzed as blocks of two daily sessions, 
and the average for the ShA sessions is shown for comparison. 
Not surprisingly, all groups increased both their total number of nosepokes (Panel 
a) and infusions (Panel b) when the test session was extended from 1 to 6 hrs/days. To 
determine whether active nosepokes differed by group during LgA sessions, an overall 
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LMM analysis with session blocks as a repeated measure was conducted on the number 
of active nosepokes during LgA sessions. There was an overall effect of group 
(F(2,43)=3.562 p<0.038), but no effect of session (F(7,43)=0.990 p=0.452), and no 
interaction (F(14,43)=0.931 p=0.535). To determine how the groups differed from one 
another during LgA sessions, each group was compared using paired repeated effects 
LMM analysis. The 5 sec group made significantly more nosepokes than the 90 sec group 
(effect of group, F(1,30)=7.625 p<0.011; interaction F(7,39)=1.103 p=0.381). Likewise 
the 45 sec group made significantly more nosepokes than the 90 sec group 
(F(1,33)=5.695 p<0.024; interaction F(7,50)=0.471 p=0.851). Fig. 3.5a shows that there 
was a tendency for the 45 sec group to make more active nosepokes than the 45 sec 
group, but this difference was not statistically significant (F(1,30)=1.245 p=0.273).  The 
reason for the trend, however, is because animals in the 45 sec group made more 
unrewarded responses during the timeout period than animals in the 5 sec group. 
Similar LMM tests were conducted to determine if there was an effect of group on 
the number of infusions obtained during LgA sessions. There was an overall effect of 
group (F(2,45)=13.986, p<0.001), but no effect of session (F(7,87)=1.842 p=0.089) and 
no group by session interaction (F(14,87)=1.718 p=0.066). The 5 sec group obtained 
significantly more infusions than the 90 sec group (group, F(1,27)=24.719 p<0.001; 
interaction (F(7,49)=3.608 p<0.004), as did the 45 sec group (F(1,30)=25.426 p<0.001). 
The 5 and 45 sec groups did not differ from one another (group, F(1,31)=0.028, p=0.868; 
interaction (F=(7,58)=1.556 p=0.167).  
In summary, it is obvious from inspection of Fig. 3.5 that animals given cocaine 
over 5 or 45 sec markedly increased the number of nosepokes and their associated 
cocaine intake by comparable rates when given 6 hrs of access to cocaine each day. In 
striking contrast, animals given cocaine over 90 sec only modestly increased their drug 
intake relative to what they took when drug was only available for 1 hr/day. Indeed, 
animals in the 5 and 45 sec groups increased their cocaine intake about 8-fold when given 
a longer time to self-administer, but despite 6-fold more time available to take cocaine, 
animals in the 90 sec group only increased their intake about 2-fold.  
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Within Session Pattern of Self-Administration 
Fig. 3.6a shows that during the LgA sessions, all animals in all groups 
discriminated between the active and inactive nosepoke ports. Although the ratio of 
active to inactive responses was highest in the 5 and 45 sec groups, the 90 sec group 
made 10-fold more responses in the active than in the inactive port, indicating they 
clearly continued to discriminate between the active and inactive ports.  
Fig. 3.6 also illustrates the temporal pattern of self-administration behavior within 
the 6 hr sessions, first by plotting cumulative infusions in 30 min bins (averaged over the 
last 6 days of LgA testing). Fig. 3.6b shows that the 5 and 45 sec groups maintained a 
stable and high rate of self-administration for the duration of the 6 hr sessions. The 
cumulative infusions in the 90 sec group was much lower than in the other groups, but 
did progressively increase as the session progressed (effect of session bin, 
F(11,46)=8.822 (p<0.001), indicating that animals in the 90 sec group continued to take 
cocaine throughout the session. This is also illustrated in Fig. 3.6c, which shows 
representative data from individual subjects (also shown in Fig. 3.3c) during session 14 
of LgA. The horizontal line represents the duration of a single six hour session and each 
vertical tick mark represents a single infusion received by the subject. Finally, the rate of 
self-administration (infusions/min) within sessions is shown in Fig. 3.6d, confirming that 
the 5 and 45 sec groups maintained a stable rate of self-administration for the entire 
duration of the session. Although the rate of self-administration in the 90 sec group was 
much lower as was expected, self-administration was not only maintained throughout the 
session, but the rate was even somewhat elevated in the last 3 hrs relative to the first 3 hrs 
of the session (effect of session bin, F(10,13)=4.365 p<0.009). This was consistent with 
the small upward deflection seen in cumulative infusions during the latter half of the 
session (see Panel b). Thus, all groups continued to self-administer cocaine throughout 
the 6 hr sessions. 
Analysis of the First Hour of the LgA Sessions 
It has been reported that when given extended access to cocaine, rats increase not 
only their total intake, but over time they escalate the amount of drug they take during the 
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first hour of each session (Ahmed and Koob, 1998, 1999; Ahmed et al., 2002). Therefore, 
I also analyzed self-administration behavior during the first hour of the extended access 
sessions. When all subjects were taken into account, animals in neither 5 sec nor 45 sec 
groups significantly escalated their number of infusions during the first hour of LgA 
sessions as compared to ShA sessions (5 sec – F(8,13)=2.312 p=0.086; 45 sec – 
F(8,17)=0.737), and animals in 90 sec group actually decreased infusions in the first hour 
over days of testing (F(8,104)=10.429 p<0.001).  
There was, however, considerable individual variation in first hour intake. 
Therefore, I divided the animals within each group into ―high performers‖ (top 50%) and 
―low performers‖ (bottom 50%), based on the total number of first hour infusions during 
the last 8 days of LgA testing. The low performers in all groups showed a small decline 
in 1
st
 hr infusions across days of LgA testing (data not shown). In marked contrast, ―high 
performers‖ in the 5 and 45 sec groups did not decrease 1
st
 hr intake over time (Fig. 3.7). 
Indeed, animals in the 5 sec group tended to increase their 1
st
 hr intake across days of 
testing (F(8,37)=2.122 p=0.058), although there was no change across time in the 45 sec 
group (F(8,26)=0.519, p=0.831). Even the high performers in the 90 sec group decreased 
their first hour intake over time (Fig. 3.7). The differences between the 5 and 45 sec 
groups evident in Fig. 3.6 were statistically significant (5 vs. 45 sec, effect of group, 
F(1,30.8)=4.187 p<0.050; interaction non-significant; 5 vs. 90 sec, effect of group 
F(1,16)=34.735 p<0.001, group by time interaction F(7,67)=2.210 p<0.045). This 
analysis suggests, therefore, that at least a subset of animals (―high performers‖) given a 
5 sec infusion of cocaine escalated their first hour cocaine intake to a greater extent than 
animals given cocaine over 45 or 90 sec. 
Discussion 
The purpose of this study was to test whether the rates of cocaine delivery shown 
in Chapter 2 to strongly influence Fos expression would also influence drug-taking 
behavior if rats were given extended access to cocaine – even if these rates do not alter 
the reinforcing effects of cocaine under more limited access conditions. The study 
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assessed  whether varying the rate of i.v. cocaine injections (5, 45 or 90 sec injections) 
would influence cocaine self-administration behavior in rat under two different 
conditions. Rats were initially tested under limited access conditions (1 hr/day), then 
subsequently allowed more extended access (6 hrs/day). Self-administration under 
limited access conditions is thought to either model more casual use in humans (Deroche-
Gamonet et al., 2004; Robinson, 2004), or tests the reinforcing qualities of cocaine 
(Headlee et al., 1955; Pickens et al., 1969). Indeed, one highly influential hypothesis as to 
why more rapid rates of drug infusion are addictive is that they are more pleasurable 
(Resnick et al., 1977; Fischman, 1984; Volkow et al., 2000; Abreu et al., 2001; Nelson et 
al., 2006), and therefore are more reinforcing (Gorelick, 1998). However, even though 
rats can distinguish between slower and faster rates of drug reward and prefer them when 
given a choice (Schindler et al., 2009), this study confirmed our previous findings that 
infusions between 5 sec and 90 sec do not significantly affect cocaine self-administration 
behavior in rats allowed only limited access to drug as infusions between 5 – 90 sec were 
equally reinforcing (also see Crombag et al., 2008).  
However, when animals were given extended access to drug, a procedure 
previously shown to produce symptoms resembling addiction in rats, striking group 
differences in drug-taking behavior emerged. Animals that had their cocaine delivered 
over 5 or 45 sec increased their total intake about 8-fold. However, despite having 6-fold 
more time to take cocaine, when cocaine was delivered over 90 sec animals only 
increased their intake by about 2-fold. This was not due to group differences in the 
opportunity to self-administer the drug, because the experimental design was such that all 
animals had the same opportunity to take exactly the same number of injections by 
keeping the minimum inter-infusion interval the same across all groups.  
n order to ensure that all groups had the same opportunity to self-administer 
cocaine, the timeout intervals were required to vary as a function of group. We 
considered, therefore, whether this influenced the reinforcing effects of cocaine, and thus 
self-administration behavior. I found that it did not. First, all rats were initially trained to 
self-administer cocaine (0.4 mg/kg/inf given over 5 sec) with each timeout interval used 
71 
 
in the latter portions of the study. During this stage of training, there was no influence of 
varying the timeout interval on self-administration behavior. Importantly, there was also 
no influence of rate of cocaine delivery (and thus also varying the timeout interval) when 
animals were tested under short access conditions. This is consistent with previous 
studies that used the same procedures as used here, even when animals were tested using 
a greater variety of schedules of reinforcement (Crombag et al., 2008). For example, 
Crombag et al. (2008) found no effect of varying the rate of cocaine or amphetamine 
delivery between 5 and 90 sec on performance on a progressive ratio schedule of 
reinforcement – all group achieved the same ―breakpoints‖. These data suggest, therefore, 
that variation in the timeout interval itself does not alter self-administration behavior by 
altering either the reinforcing effects of cocaine, or motivation for cocaine. It seems 
unlikely, therefore, that this factor is responsible for the large group differences in the 
amount of cocaine intake seen when animals were tested under extended access 
conditions.  
It is not surprising that a timeout interval of up to 90 sec has little effect on the 
rate of self-administration when one considers the typical interval between injections 
when rats are tested with much shorter timeout intervals – and therefore with greater 
opportunity to take drugs. For example, Mantsch and colleagues (2001) reported that 
when rats were given 10 hours of access to self-administer 0.5 mg/kg/inf cocaine over 5 
sec with a 20 sec timeout interval, on average they took one infusion roughly every 6 
minutes (360 sec). In addition, Belin and colleagues (2009) reported that rats given 
extended access to cocaine and showing addiction-like behaviors also develop ―burst‖-
like patterns of self-administration. However, even in animals showing the most severe 
index of addiction-like behavior, they reported a mean interinfusion interval of 3 minutes 
(180 sec). Lastly, Ferrario and colleagues reported an average interinfusion interval of 
108 sec in long access sessions with a 20 sec timeout interval and using conditioned 
stimuli associated with drug delivery, which facilitates even higher levels of drug-taking. 
Thus, rats in extended access conditions ―self impose‖ a longer interval between 
injections than was required here. Finally, even if long timeout intervals constrained self-
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administration behavior, the most likely outcome would have been a decrease in self-
administration in groups with the 85 sec timeout interval (animals receiving cocaine over 
5 sec) and an increase in self-administration in rats with no timeout interval (those 
receiving cocaine over 90 sec). This is clearly not the case; animals with the longest 
timeout interval (and fastest rate of infusion) increased their intake 8-fold while animals 
with no timeout interval only increased their intake 2-fold. 
Obviously, if an individual does not increase their drug intake when they have the 
opportunity to do so, they will be less likely to abuse drugs and to develop an addiction. 
Perhaps this is one reason that drugs or formulations that enter the brain relatively slowly 
tend to be less addictive – they do not promote increased intake. The important question, 
therefore, is if rate of infusion does not markedly alter the reinforcing effects of cocaine 
under limited access conditions, why does it have such a profound effect on self-
administration behavior under extended access conditions? 
Perhaps this increase in drug intake reflects a greater neurobiological impact of 
faster drug delivery (Samaha and Robinson, 2005). I have shown in the previous chapter 
that Fos IEG expression after 90 sec infusions is significantly lower than when the same 
dose of drug is delivered over 5 sec. Recently, increased cocaine-induced Fos expression 
has been associated with other persistent biochemical and structural changes in the brain 
related to psychomotor sensitization (Zhang et al., 2005; Xu, 2008). Therefore, addiction-
like behavior, such as a marked escalation of intake in the 5 and 45 sec groups during 
long access sessions, may reflect sensitized incentive motivational processes (Robinson 
and Berridge, 1993). Thus, while cocaine remains reinforcing when delivered over 90 
sec, as indicated by the fact that animals continue to take the drug regularly throughout 
the session, it is possible that this rate of infusion does not induce neurobiological 
changes in the brain sufficient to sensitize incentive motivational processes. In support of 
this idea, a greater neurobiological impact specific to extended access and not limited 
access self-administration has been found. Ferrario and colleagues (2005) have shown 
that escalation of drug intake during long access is associated with greater psychomotor 
sensitization and a higher density of dendritic spines in the core of the nucleus 
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accumbens. Increases in dendritic spine density in the core of the nucleus accumbens is a 
structural modification reflecting possible sensitization-related synaptic reorganization 
within the mesocorticolimbic circuitry (Li et al., 2004; Robinson and Kolb, 2004; 
Ferrario et al., 2005).  
One behavioral consequence of these drug-induced neurobiological changes in the 
mesocorticolimbic circuitry is a sensitized motivation for drug – an increased ―wanting‖ 
for drug (Robinson and Berridge, 1993). While I have shown in Chapter 2 that faster 
rates of drug infusion have a greater neurobiological impact as indicated by Fos 
expression, and in this study I have shown that faster drug delivery strongly influenced 
rates of drug-taking only during conditions able to produce addiction-like behavior, many 
questions remain. For example, if the escalation in intake observed in rats receiving 
cocaine over 5-45 sec during extended access is due to addiction-related changes in the 
brain resulting in a sensitization of incentive motivation, then only rats with prior 
experience with rapid infusions during long access should develop other symptoms 
resembling addiction. Rats with rapid infusion experience should have a greater and 
persistent motivation for drug when compared to animals with a history of extended 
access to 90 sec cocaine infusions, particularly in models testing for the propensity to 











Fig. 3.2 A representation of a typical long access session for animals in the 5, 45 and 90 
sec groups. In the bottom portion of the figure, the length of the session is represented by 
a horizontal line. Vertical tick marks represent nosepokes where animals received an 
infusion of cocaine. For clearer comparison, the inset circle shows the infusion lengths 
and timeout intervals of the three groups in the experiment. The duration of the infusion 
and following timeout interval is indicated for each group. Note that the number of 
opportunities to self-administer an injection is exactly the same in all groups because the 







Fig 3.3 Panel a: The mean (±SEM) number of active and inactive nosepokes made by all 
rats used in this experiment during self-administration training sessions. Panel b: The 
mean number of infusions made by all subjects during self-administration training 
sessions. During these training sessions all rats received the same rate of cocaine infusion 
(5 sec), and the timeout lengths were lengthened each time a rat reached criterion 
performance for self-administration. Rats began training with a 20 sec timeout interval 
and were stepped to intervals of 45, 63, and 85 sec in subsequent sessions. Data presented 
in the 85 sec timeout sessions in this figure is the average of all subjects comprising the 
―Baseline‖ data point presented in Fig. 3.3. Thus to reduce possible confounding 
contributions of timeout intervals on self-administration behavior, all rats had prior 





Fig. 3.4 Panel a: The mean (±SEM) number of active and inactive nosepokes made 
during baseline training sessions, when all rats received cocaine at the same rate (5 sec), 
and during short access (ShA) sessions when rats were assigned to groups that received 
cocaine over either 5, 45, or 90 sec. Baseline data are averaged over 2 sessions. Panel b: 
The mean (± SEM) number of infusions received during the same baseline training and 
ShA sessions as panel a. The pattern of self-administration behavior in 3 representative 
rats during ShA session 3. The horizontal line represents the duration of the session, and 








Fig. 3.5 shows the mean (± SEM) number of active nosepokes (Panel a) and cocaine 
infusions (Panel b) made by rats receiving 0.4 mg/kg/inf cocaine over 5, 45 or 90 sec 
after self-administration sessions were lengthened from 1 hour to 6 hours/day (―long 
access‖, LgA). LgA session data were analyzed as blocks of two daily sessions, and the 







Fig. 3.6 Panel a: The mean (+SEM) ratio of active to inactive nosepokes made by groups 
during long access sessions. All groups discriminated between the active and inactive 
ports. Panels b-d show how self-administration behavior was distributed within the last 6 
LgA sessions. Panel b: Mean (±SEM) cumulative infusions and total dose of cocaine self-
administered by rats receiving cocaine over 5, 45, 90 sec during 6 hr LgA sessions. Panel 
c: Infusions during LgA session 14 in the same 3 representative rats as shown in Fig 3.3c. 








Fig. 3.7 The mean (±SEM) number of infusions during the first hour of each session in 
―high performers‖ in each group, plotted over days of testing. ―High performers‖ in each 
group were those that took above the median number of injections (top 50%) during the 






CHAPTER 4  
 
DRUG-PRIMED REINSTATEMENT OF DRUG-SEEKING AND 
NEUROBIOLOGICAL ADAPTATIONS PERSISTS IN RATS WITH A HISTORY 
OF EXTENDED ACCESS TO RAPID (5 SEC) BUT NOT SLOW (45-90 SEC) 
INFUSIONS DURING COCAINE SELF-ADMINISTRATION.  
Introduction 
In the previous experiment (Chapter 3), I showed that faster (5 – 45 sec) but not 
slow (90 sec) rates of cocaine infusion are associated with marked increases in drug 
intake during extended access self-administration sessions. This is despite the fact that 
varying the rate of infusion over this range has no effect on total amount of drug that 
reaches the brain (Pan et al., 1991; Samaha et al., 2004) or the amount of dopamine 
overflow in the striatum (Ferrario et al., 2008). Although one possible explanation for this 
finding is that faster rates of cocaine are more reinforcing (Gorelick, 1998), an alternative 
hypothesis is that faster rates of drug infusion preferentially induce long lasting changes 
in the brain, resulting in the sensitized incentive motivation (Samaha and Robinson, 
2005). Sensitized motivation that induces pathological ―wanting‖ of drug and drug-
related cues could underlie drug relapse, which remains an enduring and persistent 
symptom of drug addiction in humans even after prolonged periods of abstinence 
(Robinson and Berridge, 1993; O'Brien, 1997; American Psychiatric, 2000; Hyman, 
2001; Hyman and Malenka, 2001). In support of this hypothesis, intense motivation for 
drug in humans can be provoked by many drug associated stimuli including re-exposure 
to small amounts of drug itself (Ehrman et al., 1992; O'Brien et al., 1992). 
In rats and other animals, one well established way to model relapse is by drug-
primed reinstatement of extinguished drug responding (Gerber and Stretch, 1975; de Wit 
and Stewart, 1981). This tests the ability of a small amount of drug to reinstate drug-
seeking behavior in rats with a history of self-administration training, and is a measure of 
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heightened motivation for drug (de Wit and Stewart, 1981; Markou et al., 1993; Shalev et 
al., 2002). While previous work by Crombag and colleagues (2008) in our laboratory has 
shown that the degree of reinstatement is not influenced by the rapidity of priming 
infusions, in those studies animals only had limited access to drug during self-
administration testing. I reasoned that the effect of rate of infusion on extinction and 
reinstatement may only appear in rats with a history of self-administration using 
procedures that foster the development of addiction-like behaviors (Ahmed and Koob, 
1998, 1999; Ahmed et al., 2002; Deroche-Gamonet et al., 2004; Vanderschuren and 
Everitt, 2004; Pelloux et al., 2007; Belin et al., 2008; Ben-Shahar et al., 2008). Others 
have shown that rats with a history of extended access to cocaine show a greater 
persistence for drug-seeking during extinction, a greater degree of reinstatement when re-
exposed to the drug, and have differing levels of gene expression (Mantsch et al., 2004; 
Ferrario et al., 2005; Ahmed and Cador, 2006; Kippin et al., 2006; Knackstedt and 
Kalivas, 2007).  
I hypothesized, therefore, if the rate of drug delivery to the brain influences the 
propensity to addiction, rats with a history of fast rates of infusion during extended access 
self-administration would persist in seeking drug during extinction and reinstate their 
drug-seeking behavior when challenged with cocaine to a greater degree than animals 
with similar experience in self-administration but at slower rates of drug delivery. I also 
hypothesized that rats with a history of rapid infusions during extended access self-
administration sessions may have enduring neurobiological adaptations as a consequence 
of their experience. I tested this latter hypothesis by measuring the ability of the cocaine 
priming injection used to reinstate drug-seeking behavior to also induce the immediate 
early gene, c-fos, as assessed by counting the number of cells positive for Fos protein 
using immunohistochemistry in the nucleus accumbens.  
Materials and Methods 
Male Wistar rats (Harlan, IN) weighing between 225 – 250 g upon arrival were 
used in this experiment. Rats were individually housed in a climate-controlled animal 
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colony maintained on a 14/10 light/dark cycle (lights on at 0800), with food and water 
available ad libitum. Rats were given a minimum of 5 days to habituate to the animal 
colony. All procedures were approved by the University of Michigan Committee on the 
Use and Care of Animals (UCUCA). A total of 61 rats were used in this experiment. Of 
these, 46 had previously been allowed to self-administer cocaine delivered over 5 (n=14), 
45 (n=18), or 90 sec (n=13) during daily 6 hr sessions for a total of 16 days (these are the 
same rats described in Chapter 3). One animal in the 90 sec group died during the course 
of the 30 day withdrawal and was removed from the analysis. A subset of these animals 
were used for Fos immunochemistry (5 sec, n=6; 45 sec, n=10; 90 sec, n=8), and an 
additional 15 drug naïve rats were used as controls for the immunohistochemistry portion 
of this study.  
Apparatus 
Behavioral training and testing occurred in operant chambers located in a 
different room than the animal‘s home cage, and were identical to the chambers used to 
train animals on extended access self-administration (Chapter 3). Each operant chamber 
was equipped with an infusion apparatus consisting of a 10 mL syringe installed in a 
PHM-100 pump located outside of the chamber (Med-Associates, VT) and attached via a 
length of Tygon microbore tubing to an Instech-Solomon liquid swivel (Plymouth 
Meeting, PA) mounted on a counterbalanced arm. On extinction training days, animal‘s 
catheters were attached to the liquid swivel via another length of PE tubing inserted 
within a homemade spring, but the syringes attached to those lines were empty. 
Control animals for the immunohistochemistry portion of the experiment were 
transported daily at the same time as experimental animals were put into the operant 
chambers, and placed into holding chambers consisting of red plastic buckets 25 cm in 
diameter and 36 cm in height. They were left there for the same amount of time 
experimental animals were in the operant boxes. The room housing these chambers was 
located in a different room from either the home colony or from the operant testing 
facility. The habituation room for the duration of the experiment was illuminated with a 
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red light. The purpose of this was to control for daily handling and transport from the 
home cage. 
Groups and Procedures 
An illustration of the general design of this experiment is shown in Fig. 4.1. After 
their last long access self-administration session, animals underwent 10 days of extinction 
training, using procedures similar to those described previously (De Vries et al., 1998; 
Shalev et al., 2002; Crombag et al., 2008). During these sessions, animals were taken 
from the animal colony, placed into test chambers and attached to the infusion apparatus. 
The session proceeded in an identical fashion to self-administration sessions, except that 
a nosepoke in the active nosepoke port activated the infusion pump without delivery of 
drug. Each extinction session was one hour in length. Following extinction sessions, 
animals underwent three one hour pre-reinstatement sessions where the animals were not 
connected to the infusion apparatus, and the operant chamber remained unlit for the entire 
session. Responses to either nosepoke port were recorded but had no other consequences. 
These sessions were conducted to further reduce the contribution of possible conditioned 
stimuli associated with drug delivery on nosepoking (De Vries et al., 1998), and reduce 
possible contributions of novelty introduced by the operational changes between 
extinction sessions and reinstatement sessions.  
The following day (14 days after the last self-administration session), rats were 
injected with saline IP and immediately placed in the self-administration chamber for 2 
hrs. Similar to pre-reinstatement sessions, stimuli associated with drug delivery such as 
the attachment to the infusion line, houselight, and infusion pump that might confound or 
potentiate reinstatement of drug-seeking behavior were not present for the duration of the 
session. Responses to the previously active and inactive nose-pokes were recorded, but 
had no other consequence. The next day (15 days after last LgA session), animals were 
tested for the reinstatement of drug-seeking behavior by receiving a 10 mg/kg i.p. 
injection of cocaine prior to placement into the test chamber. Thus, the first reinstatement 
test took place 15 days after the last self-administration session. Active and inactive 
nosepokes were recorded, although they had no consequence. The animals were then left 
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undisturbed for an additional 30 days, after which time the cocaine priming reinstatement 
test was repeated as described above. Thus, the second test for reinstatement took place 
45 days after the last self-administration session.  
Control rats were moved daily from the home colony room to holding chambers 
concurrently with animals undergoing self-administration training, where they were left 
undisturbed for 6 hrs a day for an average of 10 days. Control rats were matched with 
animals or groups of animals undergoing their final reinstatement test. During these days, 
control animals spent two hours in their transport chambers, mirroring the length of the 
reinstatement session. All control animals received saline injections on the same day as 
animals undergoing reinstatement testing. The following day, some control animals 
received a second saline IP injection (n=5), while others (n=10) received an acute 10 
mg/kg IP injection of cocaine. In this way, these control animals experienced the general 
effects of handing, transport, and time outside the animal colony in a distinctly different 
environment similar to self-administration animals (Ferrario et al., 2005). The control 
animals remained either drug naïve or experienced a single acute exposure to cocaine 
equivalent to the dose and route of administration as the cocaine priming injection used to 
reinstate cocaine seeking behavior in rats that had undergone extinction training.  
Immediately after the end of the second drug-primed reinstatement session or 2 
hours after injecting a transport control animal, rats were taken to a different room and 
deeply anesthetized with sodium pentobarbital (390 mg/kg i.p., Vortech, Dearborn MI), 
and transcardially perfused with 500 mL ice cold perfusion rinse (73 mM sucrose, 18 
mM procaine hydrochloride, 139 mM sodium chloride in 0.1 M sodium phosphate buffer 
(SPB), pH 7.4) followed by 250 mL ice cold paraformaldehyde rinse (4% (W/V) 
paraformaldehyde dissolved in 0.1 M SPB buffer containing 73 mM sucrose, pH 7.4). 
Brains were removed and placed in 4% formaldehyde overnight at 4 degrees Celsius, and 
then transferred to 30% (W/V) sucrose for 3 days at the same temperature. Brains were 
coronally sectioned to a 40 µm thickness with a freezing microtome. Series of sections 
were collected 120 or 160 µm apart. Sections that were processed for 
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immunohistochemistry within 2 days were stored in 0.1 M SPB, otherwise sections were 
stored at -20 Celsius in liquid cryoprotectant. 
Immunohistochemistry 
Sections were processed for Fos and Mu-opioid receptor protein 
immunofluorescence in a similar manner to Reynolds and Berridge (2007), and as 
described in Chapter 2. 
Visualization 
Sections were visualized at 100x total magnification with a Leica DM6000B 
(Wetzlar, Germany) microscope with a Leica EL6000 external fluorescent light source 
coupled to a Q-Imaging monochrome 12 bit 1.4 megapixel digital camera (Surrey, 
Canada). AlexaFlor 488 was fluoresced using a Leica L5 bandpass filter cube, and 
AlexaFlor 594 was fluoresced using a TX2 bandpass filter cube. The same section and 
region was imaged for Fos and Mu opioid immunoreactivity. Separate Fos and Mu opioid 
images were captured as LZW lossless compression TIFF files to minimize image 
compression artifacts in dark-field areas of the image and were analyzed using the MCID 
Core 7.0/Analysis (Cambridge, UK) software package. 
Sampling Areas 
The number of Fos positive cells in the core and shell of the nucleus accumbens 
was quantified, and data from the left and right hemisphere was summed together. All 
brain regions were identified by Paxinos and Watson (1998). Areas sampled are indicated 
by the grey areas in Fig. 4.2. The nucleus accumbens (NAc) shell and core were sampled 
at +2.0 mm from bregma. Mu opioid receptor expression was used to delineate the 
boundaries of the subregions of the nucleus accumbens (Heimer et al., 1997). An 
elliptical sampling area of 300 µm x 650 µm
 
was used to sample the shell, and a smaller 
sampling area of 300 µm x 450 µm
 
was used for the core. To better follow the contours 
of the shell and the core, sampling ellipses were angled. Representative images are shown 




The number of Fos positive cells was quantified as described in Chapter 2. In all 
cases the person quantifying the images was blind to the experimental conditions of each 
image. While still blind to the conditions, each image was also qualitatively rated for the 
amount of artifact and nonspecific binding on a fixed scale (1 ―none‖ – 3 ―moderate‖). 
For Fos immunoreactivity, there was a range of nonspecific binding in the Fos images 
across all experimental groups (5, 45, 90 sec, Acute Cocaine Transport Control, Acute 
Saline Transport Control). Therefore, to minimize possible contributions of nonspecific 
binding and artifact to the experiment, the means of each nonspecific binding grade group 
regardless of experimental manipulation were normalized to the grand mean of the entire 
study. Normalized Fos counts within each brain region and subregions were then 
compared. 
Statistics 
Extinction data were analyzed as bins comprised of the average of two contiguous 
daily sessions. Data with repeated measures over time were analyzed using Linear Mixed 
Models analysis (LMM) using the SPSS 16 statistical package. For each analysis, the best 
fitting model of repeated measures covariance was determined by the lowest Akaike 
Information Criterion (AIC) score (West, 2007). Between-group comparisons were made 
by one-way analyses of variance (ANOVA) or two-way ANOVAs, followed by Fisher's 
LSD post-hoc tests or one tailed t-tests, when appropriate.  
Results 
Extinction 
Fig. 4.3 shows the number of active and inactive nosepokes by animals in each 
group during the 10 days of extinction training. Active nosepokes are illustrated by 
symbols, while inactive nosepokes are shown as lines. A LMM analysis on inactive 
nosepokes revealed no group (F(2,44)=1.672 p=0.200), session (F(4,44)=1.676 p=0.173) 
or interaction effects (F(8,44)=1.135 p=0.359). There was a comparable decrease in 
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active nosepokes over time in all groups (effect of session F(4,43)=5.598 p<0.006; effect 
of group, F(2,43)=2.056 p=0.140; interaction, F(8,43)=1.169 p=0.340). There were no 
significant group differences on the last extinction session bin, indicating that all animals 
had extinguished their level of response to the same degree (F(2,43)=1.427 p=0.2511). 
First Reinstatement Test (15 days after the last self-administration session) 
Fig. 4.4 (Panel a) shows the number of nosepokes after an IP priming injection of 
either saline or cocaine given 15 days after the last self-administration session and 
extinction training. Active nosepokes are represented by bars and inactive nosepokes are 
represented by inset bars. Animals in all groups reinstated responding following a 
cocaine priming injection, as indicated by a significant increase in the number of active 
nosepokes, and there were no significant group differences in the degree of reinstatement 
(main effect of treatment F(1,84)=9.403 p<0.004; no effect of rate of infusion (ROI) 
history, F(2,84)=0.371, p=0.691; no treatment x ROI history interaction, F(2,84) 
p=0.094). There were no effects of treatment (saline vs. cocaine priming injection), ROI 
history or interaction on inactive nosepoke responding (treatment F(1,84)=0.5937 
p=0.2159; ROI history F(2,84)= 1.31 p=0.5546; Treatment x ROI history interaction 
F(2,84)=3.67 p=0.194).  
Second Reinstatement Test (45 days after the last self-administration session) 
Fig. 4.4 (Panel b) shows the number of nosepokes during the test for 
reinstatement conducted 45 days after the last self-administration session, and 30 days 
after the first reinstatement session. On this test there were significant group differences 
in reinstatement. For active nosepokes, a two-way ANOVA resulted in a significant main 
effect of treatment (F(1,84)=6.081 p<0.017) and of ROI history (F(2,84)=3.991 p<0.023), 
and the treatment by ROI history interaction was almost significant (F(2.84)=2.967 
p=0.057). To determine which groups reinstated responding, active nosepokes following 
the cocaine prime were compared with those produced by an injection of saline. Only 
animals that previously received cocaine over 5 sec showed significant reinstatement 
(t(13)=2.383 p<0.0167). In this test animals in both the 45 and 90 sec groups did not 
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significantly increase active nosepokes, relative to that seen following a saline injection 
(45 sec group, t(17)=1.070, p=0.149; 90 sec group, t(12)=1.256, p=0.1166). 
Similar to the first reinstatement test, there were no significant effects of 
treatment or ROI history on the number of inactive nosepokes (treatment, F(1,84)=0.1261 
p=0.7234; ROI history, F(2,84)=1.859 p=0.1621; treatment x ROI interaction, 
F(2,84)=0.0022 p=0.9978).  
Fos Immunoreactivity After Cocaine Priming 
Representative images showing Fos positive cells and areas sampled within the 
nucleus accumbens core and shell are shown in Fig 4.2.  
Fig. 4.5 illustrates the number of Fos positive nuclei per mm
2
 in the core and shell 
of the nucleus accumbens two hours after an IP priming injection of cocaine on the 
second reinstatement test day. There were significant effects of drug history on the ability 
of a cocaine injection to induce Fos in the nucleus accumbens. 
In the NAc shell, a one-way ANOVA on the number of Fos positive nuclei 
revealed a main effect of group (F(4,34)=3.901, p<0.011). Relative to animals given 
saline, cocaine increased the number of Fos positive cells in all groups, except in the 5 
sec group (5 sec group, p=0.363; 45 sec group, p<0.004; 90 sec, p<0.007; acute cocaine 
control group, p<0.008). The 45 sec, 90 sec and acute cocaine control groups did not 
differ from one another, and all showed significantly greater Fos expression than the 5 
sec group (5 sec vs. 45 sec, p<0.028; vs. 90 sec, p<0.047; vs. acute cocaine control, 
p=0.059).  
For the NAc core, a one-way ANOVA also indicated there were significant group 
differences in the number of Fos positive cells (F(4,34)=8.168 p<0.001). Compared to the 
saline control group, a cocaine injection increased the number of Fos positive cells in the 
45 sec group (p<0.001), the 90 sec group and the acute cocaine control group (p<0.003), 
and these groups did not differ from one another. In marked contrast, cocaine failed to 
increase Fos expression in the 5 sec group (5 sec vs. saline, p=0.357), and the 5 sec group 




In summary, in animals with a history of self administering cocaine delivered 
over 5 sec, the ability of a cocaine challenge injection to induce Fos 45 days after the last 
self-administration session was markedly suppressed, relative to animals with a history of 
self administering cocaine delivered over either 45 or 90 sec. There appears to be, 
therefore, long term alterations in the nucleus accumbens produced by a previous history 
with self administered cocaine when it is administered rapidly (over 5 sec) that are not 
evident when it is administered more slowly (45 – 90 sec).  
Discussion 
In the previous chapters, I reported that faster rates of cocaine delivery have a 
greater neurobiological impact on the brain as indicated by IEG expression, and this is 
associated with marked increases in drug intake only when rats are allowed extended 
access to cocaine. Although one possible explanation for this finding remains that faster 
rates of cocaine are more reinforcing (Gorelick, 1998), this study tested our hypothesis 
that the escalation of intake in animals receiving drug rapidly during long access sessions 
was due to sensitized incentive motivational processes as a result of faster drug delivery 
having a greater neurobiological impact on the brain (Samaha and Robinson, 2005).  
Sensitized motivation that induces pathological ―wanting‖ of drug and drug 
related cues could underlie drug relapse, an enduring and persistent hallmark of drug 
addiction in humans, even after prolonged periods of abstinence (Robinson and Berridge, 
1993; O'Brien, 1997; American Psychiatric, 2000; Hyman, 2001; Hyman and Malenka, 
2001). Indeed, recent human studies have supported the idea that intense, pathological 
desire for drug precedes and increases prior to cocaine taking events, and remains 
elevated during periods of use (Preston et al., 2009). In addition, diagnosed addicts report 
a greater desire for cocaine than casual users when exposed to i.v. cocaine in the 
laboratory, show a greater motivation for drug, and are more susceptible to tests 
measuring relapse liability (Walsh et al., 2009).  
In the rat, experience with extended access to cocaine self-administration is 
associated with many symptoms of addiction-like behavior. Importantly for this 
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discussion, such history can facilitate an increase in drug-seeking behavior when drug is 
not available (Ferrario et al., 2005), and can potentiate the reinstatement of extinguished 
drug-seeking behavior when challenged with a small priming dose of drug (Mantsch et 
al., 2004; Ferrario et al., 2005; Ahmed and Cador, 2006; Kippin et al., 2006; Knackstedt 
and Kalivas, 2007). Both have been interpreted as a measure for increased motivation for 
drug and drug related cues (Markou et al., 1993; Leri and Stewart, 2001). Extended 
access experience also potentiates the reinstatement of drug-seeking behavior when 
challenged with a small priming dose of drug. Increases in cocaine reinstatement after 
long access experience is also associated with enduring neurobiological changes in the 
mesocorticolimbic circuits, such as differences in striatal preproenkephalin neuropeptide 
gene expression (Mantsch et al., 2004) and dendritic spine density (Ferrario et al 2005). 
These neurobiological changes can be accompanied by increases in psychomotor 
sensitization (Ferrario et al 2005), a behavioral symptom of the sensitized incentive 
motivational processes associated with the neurobiological changes induced by repeated 
exposure to drug (Robinson & Berridge 1993). 
In the present study, I found that different rates of infusion during extended access 
self-administration had no effect on extinction learning, indicating that early after the 
cessation of self-administration there was no effect on continued drug-seeking under 
these extinction conditions. Furthermore, when animals were tested for drug-induced 
reinstatement soon after extinction training, all groups reinstated cocaine-seeking 
behavior to a similar extent. This reinstatement was not the result of a generalized 
behavioral activation as evidenced by little or no increases in responding to the nosepoke 
port that was previously inactive (Shalev et al., 2002). These findings resemble those of 
Crombag and colleagues (2008) in rats given only limited access to drug and tested 
immediately after extinction training.  
In contrast, when animals were tested for reinstatement 45 days after the last 
extended access self-administration session, and 30 days after the first test for 
reinstatement, only animals with a history of 5 sec infusions showed significant 
reinstatement of drug-seeking following a priming injection of cocaine. This is 
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particularly striking when taking into account the history of the 45 sec group – they had 
taken similar amounts of drug as the 5 sec group during extended access self-
administration sessions. This suggests that a high level of total cocaine intake during self-
administration alone was not sufficient to render animals liable to reinstatement after 
prolonged withdrawal. 
An examination of Fos expression induced by the cocaine priming injection also 
yielded evidence that a history of rapidly administered cocaine (5 sec) had different, 
long-lasting neurobiological effects than a history of cocaine delivered more slowly (45 – 
90 sec). In both the core and shell of the accumbens, the ability of a cocaine priming 
injection to induce Fos expression was significantly attenuated in animals with a history 
of extended access to 5 sec infusions during self-administration. Desensitization of Fos 
expression in response to a cocaine challenge as a consequence of chronic treatment has 
previously been reported (Hope et al., 1992; Couceyro et al., 1994; Daunais and 
McGinty, 1994; Daunais et al., 1995; Moratalla et al., 1996; Willuhn et al., 2003). Similar 
attenuated expression in the NAc was also seen in rats after 30 days of abstinence with 
extended but not limited access cocaine self-administration (Ben-Shahar et al., 2004). It 
should be noted that similar attenuation of Fos expression occurred despite the fact that 
the rats underwent extinction training, which has previously been shown to effect 
experience dependent plasticity in the nucleus accumbens shell (Sutton et al., 2003). 
Also, repeated rapid infusions of nicotine are more effective in suppressing c-fos gene 
expression in the mesocorticolimbic circuit than slower infusions (Samaha et al., 2005).  
Desensitization of Fos expression can be a result of the long-term 
neuroadaptations initially induced by Fos serving as a negative feedback mechanism for 
its further activation (Zhang et al., 2006; Renthal et al., 2008; Xu, 2008). One candidate 
transcription factor is ∆FosB. ∆FosB is a modified 35-37 kD Fos transcription factor 
from the fosB gene homologous with c-fos (Morgan and Curran, 1991) and can also form 
functional AP-1 subunits, influencing the transcription of downstream targets (Chen et 
al., 1997; Hiroi et al., 1998). But in contrast to c-fos, ∆FosB has a long half-life (Chen et 
al., 1997; Nestler, 2008) and accumulates in the nucleus accumbens as a result of repeat 
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exposure drugs such as cocaine. The over-expression of ∆FosB in the nucleus accumbens 
in transgenic mice is associated with greater psychomotor activation after acute or 
chronic treatment with cocaine (Kelz et al., 1999), and greater sensitivity to the rewarding 
effects of cocaine during self-administration (Colby et al., 2003; Nestler, 2008). Recently, 
∆FosB has been shown to suppress the transcription of c-fos mRNA through chromatin 
remodeling; high levels of ∆FosB result in the deactylation of histones surrounding the c-
fos gene, resulting in a tighter association of the DNA containing the c-fos gene with 
histones and deactivating the c-fos gene (Renthal et al., 2008).  
Thus, suppressed Fos expression can be viewed as an indicator of more persistent 
drug-induced neuroadaptations in animals with a history of exposure to rapidly 
administered cocaine. That is, it appears that a history of 5 sec infusions during extended 
access facilitates the persistence of neuroadaptations in the nucleus accumbens, and this 
is associated with an increased propensity to reinstate drug-seeking behavior after 
prolonged abstinence. These neuroadaptations and vulnerability towards drug 
reinstatement can occur independently of the total amount of drug consumed by the 
animal, highlighting the importance of the rapidity of drug delivery to the brain as a 




Fig. 4.1 An illustration of the experimental design. Icons depict the number of sessions 








Fig. 4.2 Examples of Fos positive nuclei in the nucleus accumbens +2.0 from bregma 
(labeled in green) at the end of the reinstatement session 2 hours after a 10 mg/kg i.p. 
priming injection of cocaine. Core and shell divisions sampled within the nucleus 
accumbens are indicated by the white ellipses, and correspond to gray areas marked on 







Fig. 4.3 The mean (±SEM) number of nosepokes made by animals in each group during 
extinction training when cocaine reward was not available. Active nosepokes are shown 








Fig. 4.4 Panel a shows the mean (+SEM) number of nosepokes during the first 
reinstatement test, conducted 14-15 days after the last self-administration session, and 3 
days after extinction training was completed. On Day 14 all animals received an injection 
of saline IP (Sal) and the next day (Day 15) an injection of cocaine IP (Coc). Panel b 
shows data from the second reinstatement test, which was conducted 45 days after the 
last self-administration session and 30 days after the first reinstatement test. The number 








Fig. 4.5 The mean (+SEM) number of Fos positive nuclei in the nucleus accumbens (+2.0 
mm from bregma) core and shell subdivisions two hours after an IP cocaine priming 
injection (10 mg/kg) in rats with a history of cocaine self-administration, when cocaine 
was delivered IV over 5, 45 or 90 sec, relative to control animals with no history of 
cocaine self-administration and given an IP injection of either saline (S) or cocaine for 








CHAPTER 5  
 
DISCUSSION 
In the preceding chapters, I explored whether relatively rapid rates of i.v. cocaine 
delivery, which promotes psychomotor sensitization (Samaha et al., 2002), also has a 
greater neurobiological impact on the brain, and on drug-taking behavior. In the first 
study (Chapter 2), I found that varying the rate of an acute infusion of cocaine had 
marked effects on the ability of cocaine to increase expression Fos in the dorsal and 
ventral striatum – fast rates (5 sec) induced greater levels of Fos expression than slower 
rates (25 – 100 sec) and this effect was equally evident in the patch and matrix 
subcompartments of the dorsal striatum, suggesting that fast rates of infusion had a 
widespread impact on this structure. In a second study (Chapter 3), I showed that faster 
rates of cocaine infusion (5 – 45 sec) facilitated an escalation in overall drug intake when 
rats were given extended access to cocaine, a procedure modeling one aspect of human 
addiction. In contrast, slow rates of cocaine infusion (90 sec) in similar conditions only 
modestly increased drug-taking behavior. In a third study (Chapter 4), I found that fast (5 
sec) rates of cocaine infusion during extended access self-administration were associated 
with a persistent susceptibility to reinstate drug-seeking behavior in response to a drug 
induced priming injection, and that this was accompanied by a persistent change in the 
ability of cocaine to induce Fos protein expression in the nucleus accumbens. 
Functional implications of Fos expression induced by rapid cocaine 
delivery 
In the first study, (Chapter 2) I found that the neurobiological impact of cocaine in 
the striatum was greater when the drug was delivered more rapidly (5 sec), as assessed by 
its ability to induce the IEG, Fos. Some skepticism has persisted about the relevance of 
measuring Fos induction in neurons due to the multiplicity of stimuli that can induce its 
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expression and questions surrounding its functional role (Hyman et al., 1993). However, 
functional roles of Fos in mediating the brain‘s response to cocaine have recently been 
discovered in several key studies, suggesting that increased Fos expression resulting from 
rapid rates of cocaine delivery is associated with long-term and persistent changes in the 
brain.  
In one example, transgenic mice with targeted c-fos gene deletions in D1 
receptors expressing striatal MSNs show marked differences in their behavioral and 
neurobiological response to cocaine, while still expressing D1 receptors and otherwise 
appearing normal (Zhang et al., 2006; Xu, 2008). Given acutely, these mutant mice show 
an attenuated psychomotor response to a high dose of cocaine in addition to a reduced 
expression of Fos. Given chronically, these mice show attenuated psychomotor 
sensitization. These mutants also show marked reductions in the neurobiological impact 
of cocaine compared to wild-type controls, which is evident in the decreased levels of 
AP-1 binding protein, which is the functional transcription factor formed by the 
dimerization of Fos protein with Jun (Morgan and Curran, 1991). These mutants also 
show attenuated expression of many other downstream proteins including the 
transcription factor ∆FosB, which is associated with psychomotor activation after acute 
or chronic treatment with cocaine (Kelz et al., 1999), and greater sensitivity to the 
rewarding effects of cocaine during self-administration (Colby et al., 2003; Nestler, 
2008). Other proteins which exhibit lower levels of expression after chronic treatment in 
these mutants including Cdk5, a transcription factor important in neuronal structural 
changes (Bibb et al., 2001), and the NMDA NR1 glutamate receptor subunit, a 
neurotransmitter receptor subunit implicated in stimulant-induced sensitization (White 
and Kalivas, 1998; Wolf, 1998). These mutants also exhibit less dendritic density and 
branching after treatment, important markers for structural plasticity associated with 
psychomotor sensitization (Robinson and Kolb, 2004). In this way, faster rates of cocaine 
delivery resulting in greater Fos expression in D1 expressing MSNs may result in 
enduring neurobiological adaptations in these neurons.  
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Increased Fos expression as a result of faster rates of infusion may also 
functionally impact D2 receptor expressing MSNs, since varying the rate of an acute 
cocaine infusion has similar effects on c-fos mRNA expression in enkephalin (Enk+) 
positive and enkephalin negative (Enk-) neurons in the dorsomedial striatum (Samaha et 
al., 2004). While Enk- MSNs predominantly express dynorphin and D1 receptors, Enk+ 
neurons co-express dopamine D2 receptors, and comprise a functionally distinct 
―indirect‖ striatopallidal pathway in the striatum (Gerfen and Young, 1988; Gerfen et al., 
1990; Le Moine et al., 1990). While injections of acute cocaine itself can induce Fos 
activation in D2 expressing MSNs (Dilts et al., 1993; LaHoste et al., 1993; Ruskin and 
Marshall, 1994), this effect is strongly mediated by environmental factors associated with 
drug (Badiani and Robinson, 2004). For example, when drugs such as cocaine or 
amphetamine are given in novel environments distinct from the homecage, Fos 
expression is potentiated in the striatum primarily in D2 receptor expressing MSNs 
(Badiani et al., 1998, 1999). This difference in Fos expression is also associated with a 
facilitation in psychomotor sensitization. Novel environments and their cues can increase 
the ability of cocaine and amphetamine to induce psychomotor sensitization – the same 
dose of drug that can induce psychomotor sensitization fails to do so in the homecage 
(Badiani et al., 1995; Badiani et al., 1995). A similar functional role for Fos expression in 
the nucleus accumbens in mediating this kind of specific psychomotor sensitization has 
recently been demonstrated. Selectively targeting and inhibiting the activity of Fos-
expressing and presumably D2 receptor expressing MSNs in the nucleus accumbens 
through a novel c-fos-LacZ daunorubicin system attenuated context-dependent cocaine 
sensitization (Koya et al., 2009). Thus, in addition to having effects on D1 receptor 
expressing MSNs, faster rates of cocaine infusion could also precipitate long lasting 
neurobiological adaptations in D2 expressing MSNs.  
To the extent that Fos expression in the striatum after an acute infusion of cocaine 
is largely dependent on D1 dopamine receptors, the results of my experiments strongly 
suggest that D1 dopamine receptors in the striatum may be exquisitely sensitive to the 
temporal dynamics of dopamine occupancy. After all, while the only difference in 
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dopamine between 5 – 100 sec is the time to peak levels (Ferrario et al., 2008), these rates 
have strikingly different effects on Fos expression. Stimulation of striatal dopamine D1 
receptors in vivo, either by the administration of direct or indirect dopamine agonists such 
as SKF-82958 or amphetamine initiates a complex series of events mediated by G-protein 
coupled interactions (e.g. Seeman and Van Tol, 1994), with one consequence leading to 
the desensitization of the dopamine receptor via internalization and intercellular 
trafficking to endosomes prior to recycling back into the synaptic membrane (Dumartin et 
al., 1998). While Dumartin and colleagues (1998) examined the effect of an acute striatal 
injection of SKF-82958 delivered over 2 minutes, the results of my experiment suggest 
this and other intracellular processes may be even more sensitive to the rate of receptor 
occupancy. To my knowledge few if any researchers have examined the effects of 
dopamine receptor dynamics at such a short time frame, and this should be examined. 
After all, effects on dopamine receptor dynamics over these very rapid time frames are 
not outside the realm of possibility. Other neurotransmitter receptor systems such as 
AMPA receptors in the brain have recently been shown to have even subsecond 
responses to repeated stimuli – AMPA receptors can quickly move in and out of the 
active zone of a synapse by moving laterally (Heine et al., 2008).  
As well as post-synaptic alterations in the nucleus accumbens mediated by Fos 
expression, faster rates of cocaine delivery could also result in a long-term increase in 
dopamine release. Although the rate of an acute infusion of cocaine does not influence 
the peak levels or total amount of dopamine in the striatum (Ferrario et al., 2008), chronic 
treatment of drugs such as cocaine and amphetamine that result in behavioral 
sensitization also results in an enhanced release of dopamine in the mesocorticolimbic 
system (medial prefrontal cortex, dorsal striatum and nucleus accumbens) following a 
challenge injection, particularly after prolonged periods of withdrawal (Robinson and 
Becker, 1982, 1986; Kalivas and Stewart, 1991; Vezina, 2004). Thus one plausible locus 
for enhanced dopamine release in the nucleus accumbens is potentiated release from 
neurons projecting from the ventral tegmental area. For example, animals sensitized by 
direct injections of amphetamine into the ventral tegmental area show enhanced 
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motivation for the same drug during progressive ratio schedules of self-administration 
and increased dopamine in the nucleus accumbens (Vezina et al., 2002). While 
dopaminergic cells in the ventral tegmental area that project to the nucleus accumbens 
themselves do not express D1 dopamine receptors, Vezina (2004) has proposed that the 
local somatodentritic release of dopamine from ventral tegmental area dopamine neurons 
to D1 dopamine receptors expressed on the pre-synaptic afferents of GABAergic and 
glutamatergic neurons form a local feedback loop that can influence the activity of 
dopaminergic afferents to the nucleus accumbens. Thus changes in local dopamine 
neurotransmission in the ventral tegmental area can alter the release of dopamine in the 
ventral striatum. Whether varying the rate of drug delivery directly into the ventral 
tegmental area influences the development of sensitization and induces greater dopamine 
release into the nucleus accumbens is an interesting question worth examining in the 
future. 
In addition to glutamate projections to midbrain dopamine neurons, corticostriatal 
glutamate neurotransmission has also previously been implicated in the expression of 
psychomotor sensitization (Pierce et al., 1996). More recently, real-time measurements of 
striatal glutamate have revealed that chronic treatment of cocaine rapidly increases 
extracellular glutamate levels over successive treatments (Lee et al., 2008). Indeed, 
cortical glutamate neurotransmission and its neuromodulation due to nonsynaptically 
released glutamate by the cystine/glutamate antiporter within the nucleus accumbens 
undergoes extensive neuroadaptation in response to chronic cocaine treatment (Kalivas, 
2009). In addition, pharmacological inhibition of ventral medial prefrontal cortex neurons 
including those in the infralimbic cortex can attenuate extinction responding 30 days after 
self-administration sessions, demonstrating a functional role of the infralimbic cortex 
(Koya et al., 2009). However, while I observed elevated Fos expression in the infralimbic 
cortex after an acute infusion of cocaine, there was no effect of rate of infusion – all rates 
of cocaine equally induced Fos expression. This differed from the results of Samaha and 
colleagues (2004) where 5 sec rates of cocaine infusion induced much more c-fos mRNA 
expression in the infralimbic cortex than rates over 25 – 100 sec. While it is possible that 
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post-transcriptional regulation of c-fos mRNA on factors influencing its translation may 
have played a role in influencing Fos protein expression (Rahmsdorf et al., 1987), 
interpretation of Fos expression in cortical areas is also complicated by the fact that Fos 
expression can be induced either by neuronal excitation or inhibition (Farivar et al., 2004; 
Zahm et al., 2009). In addition, while faster rates of acute cocaine infusion induced 
distinct patterns of striatal Fos expression depending on the subregion of the striatum, this 
effect was equally evident in the patch and matrix subcompartments, indicating that Fos 
expression was equally upregulated by rapid rates of cocaine infusion in functionally 
distinct subcompartments (White and Hiroi, 1998; Lawhorn et al., 2009). Additionally, 
work by Venton and colleagues (2006) with highly sensitive microdialysis coupled to 
capillary electrophoresis with laser-induced fluorescence detection techniques showed 
that acute 5 sec infusions of cocaine do not detectably increase levels of glutamate in the 
striatum.  
In summary, varying the rate of cocaine delivery can have a profound and 
widespread impact on Fos expression in the striatum. This upregulation in Fos expression 
can have functional consequences related to the development of psychomotor 
sensitization and the initiation of gene cascades which can persistently alter the processes 
mediating incentive motivational attribution to drug related cues (Robinson and Berridge, 
1993; Samaha and Robinson, 2005). How faster rates of acute drug delivery can 
preferentially upregulate Fos expression is still virtually unknown. Many different pre- or 
post-synaptic mechanisms systems could contribute towards this effect. Nevertheless, the 
results reported here raise a challenge the field of neuroscience and pharmacology to 
further examine the influence of small variation in the temporal dynamics of receptor 
occupancy on the intracellular signaling cascades that alter gene expression.  
Faster rates of drug infusion facilitate an escalation in overall drug intake – 
increased cocaine reinforcement, tolerance or incentive sensitization? 
In Chapter 3 of this dissertation, I showed that faster rates of cocaine infusion 
have a greater neurobiological impact and facilitate an escalation in overall intake while 
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the reinforcing effects of cocaine remain unchanged. I came to this conclusion based on 
several key points. While previously conducted work in the laboratory suggested that 
faster rates of cocaine infusion had a profound impact on the brain and could induce 
psychomotor sensitization (Samaha et al., 2002; Samaha et al., 2004), extensive testing 
using self-administration and related paradigms under limited access conditions failed to 
find differences in cocaine self-administration behavior (Crombag et al., 2008). This was 
evident even though rats can differentiate between the rates of cocaine infusion and 
prefer faster rates over slower ones when given a choice (Schindler et al., 2009).  
During limited access sessions, cocaine infusions were equally reinforcing across 
5 – 90 sec. Only when rats were allowed extended access to cocaine self-administration 
did they begin to show marked differences in drug-taking. This finding supports the 
underlying reasoning behind my initial hypothesis: testing the reinforcing effects of a 
drug under limited access sessions may not adequately model all of the factors 
influencing its addiction liability. Only under conditions amenable to the development of 
addiction-like behaviors will the influence of some factors mediating the addictive 
liability of a drug emerge. In contrast to limited access conditions, extended access self-
administration is associated with the development of many addiction-like behaviors 
(Ahmed and Koob, 1998, 1999; Ahmed et al., 2002; Ahmed and Cador, 2006), such as 
greater motivation for drug both when available (Paterson and Markou, 2003; Deroche-
Gamonet et al., 2004; Belin et al., 2008) and not (Deroche-Gamonet et al., 2004; 
Robinson, 2004), resistance to adverse consequences associated with drugs, (Deroche-
Gamonet et al., 2004; Vanderschuren and Everitt, 2004; Pelloux et al., 2007; Belin et al., 
2008), changes in the pattern of drug-taking (Ahmed and Koob, 1998, 1999; Ahmed et 
al., 2002; Ahmed and Cador, 2006; Belin et al., 2009), and a persistence to reinstate drug 
seeking behavior (Deroche-Gamonet et al., 2004; Ferrario et al., 2005; Knackstedt and 
Kalivas, 2007; Belin et al., 2009). Extended access conditions have also been shown to 
induce psychomotor sensitization and structural plasticity, both symptoms of adaptations 
in the brain as a result of repeated drug administration (Ferrario et al., 2005).  
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Similar to human addiction where the condition has many symptoms (Robinson 
and Berridge, 1993; Deroche-Gamonet et al., 2004; Robinson, 2004) with a complex 
diagnostic criteria (American Psychiatric, 2000), the severity of reinstatement in rats 
allowed extended access to cocaine can predict the severity of other associated addiction-
like behaviors (Deroche-Gamonet et al., 2004; Belin et al., 2009).  
This correlates with results from the acute infusion study in Chapter 2, where I 
found that while the intermediate rate of infusion (25 sec) induced similar amounts of low 
Fos expression as the 90 sec group, drug-taking in rats receiving a comparable rate (45 
sec) resembled that of the 5 sec group in amount of drug consumed over the extended 
access sessions. These results would be confusing if one considers drug-taking in the 
extended access condition as the singular behavioral measure of addictive liability. 
However, considering the totality of each group‘s behavior, including their first hour 
intake and propensity to reinstate their cocaine seeking behavior, perhaps the results of 
the three experiments will become clearer.  
Although the 45 sec group consumed very similar amounts of drug over the entire 
session as the 5 sec group, their behavior differed from the 5 sec group in two ways. One 
such measure was quantity of drug consumed in the first hour (Ahmed and Koob, 1998, 
1999; Ahmed et al., 2002). Although there was a large contribution of individual 
differences in both 5 and 45 sec groups, ―high performers‖ in the 5 sec group differed 
significantly from those in the 45 sec group by escalating the amount of drug consumed 
over the extended access sessions. ―High performers‖ from the 45 sec group did not. The 
second measure where the 5 sec and 45 sec rats differed was during reinstatement – only 
animals with a history of 5 sec infusions during extended access reinstated their cocaine 
seeking behavior 45 days after their last self-administration session.  
If reinstatement was considered as the sole behavioral measure of addiction-like 
symptoms, results from the first reinstatement test would seem to conflict with the results 
from the acute infusion study in Chapter 2. The pattern and overall intake of drug during 
extended access sessions, particularly in light of the persistence to reinstate drug seeking 
at 45 days after their last self-administration session, would also seem contradictory. 
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However, taking into account all behaviors, the data suggests that the 5 sec animals 
overall manifest the most severe addiction-like symptoms: 1) a tendency to escalate 
intake rapidly over the first hour of extended access (Ahmed and Koob, 1998, 1999; 
Ahmed et al., 2002), 2) marked increases in overall drug intake and 3) a persistence to 
seek drug during reinstatement tests (Deroche-Gamonet et al., 2004; Belin et al., 2009). 
Animals in the 5 sec group also had enduring neuroadaptations in the nucleus accumbens, 
reflecting a change in systems in the brain mediating incentive motivational attribution 
toward drug related cues (Samaha and Robinson, 2005). 
Of course, this is not meant to reduce the contribution of drug-reinforcement 
towards addiction. It is critical to consider that addiction is a multi-symptom disease and 
may have many contributing mechanisms towards its etiology (Robinson and Berridge, 
1993; Jentsch and Taylor, 1999). After all, the reinforcing effects of cocaine and crack 
cocaine at these rates can be subjectively different in humans (Abreu et al., 2001), and 
drug euphorogenesis is likely to play a role in initiating drug use; after all, heuristically it 
seems unlikely that people initiating crack cocaine use do so with the express goal of 
becoming addicted. In addition to reinforcement and incentive sensitization, tolerance is 
also considered to play important roles in the mechanisms of addiction. 
One view suggests that tolerance towards the negative properties of drugs 
(Lasagna et al., 1955) mediates the escalation in drug intake. Indeed, cocaine can produce 
potent aversive anxiogenic effects concomitant with its positive subjective effects in both 
humans and rats (Mulvaney et al., 1999; Ettenberg, 2009). From this perspective, drug 
addicts take greater and greater amounts of drugs to experience greater subjective effects 
because they can tolerate the unpleasant or even life-threatening negative effects of the 
drug (Robinson and Berridge, 1993). For example, when rats are trained on a runway 
model of self-administration where they are required to traverse a runway from a ―start 
box‖ to a ―goal box‖ where upon entry they can receive an infusion of cocaine, rats 
pretrained with limited access cocaine self-administration show progressively slower 
―run times‖ towards the goal box (a measure of motivation for drug) and increased 
numbers of retreats from the threshold of the goal box to the start box (a measure of the 
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anxiogenic effects of the drug since this behavior can be mitigated by antianxiety drugs, 
see Ettenberg and Bernadi, 2006). In contrast, rats with a previous history of extended 
access self-administration show faster runtimes towards the ―goal box‖, showing greater 
motivation for cocaine, and a decreased number of retreats (Ben-Shahar et al., 2008). 
Although this suggests that extended access self-administration experience results in 
tolerance towards the anxiogenic effects of cocaine, it should be noted that when a 
separate of animals were trained on long access self-administration and tested on an 
Elevated Plus Maze (a different test of anxiety) limited and extended access animals 
performed similarly, although these results may be the result of procedural differences. 
Regardless, tolerance towards the anxiogenic effects of cocaine remains an interesting 
alternate hypothesis for the effects of rate of infusion on extended access self-
administration, mainly because there is some recent evidence to suggest that the 
anxiogenic effects of cocaine are dissociable neurobiologically from either the incentive 
motivational or reinforcing effects (Guzman et al., 2009). Whether varying the rate of 
cocaine delivery during extended access self-administration influences the anxiogenic 
effects of cocaine is not yet known.  
Alternatively, the ―hedonic allostasis‖ view suggests that negative affective states 
associated with the symptoms of drug withdrawal, such as dysphoria, irritability, and 
anxiety during abstinence (Gawin and Kleber, 1988) provides the motivation for drug-
taking in addiction (Koob and Le Moal, 2001). The hedonic allostasis hypothesis of drug 
addiction (Koob and Le Moal, 2001) posits that the development of drug addiction stems 
from dysregulation of normal homeostatic mechanisms in the brain that regulate reward. 
In this view, the normal drug naïve brain has two automatic and opposing processes 
(Solomon and Corbit, 1974) that normally regulate the impact of positive reinforcers – a 
positive hedonic process which is opposed by a negative hedonic process (Koob and Le 
Moal, 1997). These negative processes are slower and take longer to act than the positive 
processes, and ultimately serve to return the brain to a ―set point‖ reflecting balanced 
homeostasis. In this view, the initial euphoric effects of drugs like cocaine are mitigated 
by the subsequent negative hedonic process of withdrawal. Changes in the positive and 
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negative opponent processes regulating reward, or ―hedonic allostasis‖ have been 
proposed as an explanation for addiction. Thus, repeated exposure to drug causes a 
chronic deviation to gradually develop in all of the regulatory systems regulating drug 
reward from the normal state of operation (allostatic state), masking the initial positive 
hedonic effects of the drug. In other words, with each drug treatment, drug withdrawal 
does not balance the ―high‖ or ―rush‖ and results in a persistent state of withdrawal even 
after a prolonged period of abstinence. 
A recent study using increased intracranial self stimulation thresholds (ICSS) as a 
measure of decreased reward sensitivity (i.e. increased negative hedonic processes due to 
withdrawal) between limited access and LgA rats (Ahmed et al., 2002) concluded that 
increased escalation of cocaine intake was associated with persistent decreases in brain 
reward function. That is, increased cocaine intake is a compensatory response to the 
brain's lowered hedonic ―set-point.‖ Thus, one interpretation of our results with the 
reward allostasis hypothesis would be that faster rates of cocaine administration can 
induce greater symptoms of withdrawal. However, there is some evidence from studies of 
opiate replacement therapies to suggest that slower rates of drug administration 
(methadone) are associated with more severe and long-lasting withdrawal symptoms than 
heroin (Gossop and Strang, 1991), a drug that can also induce escalation in intake during 
extended access self-administration (Ahmed et al., 2000). If so, I would have expected in 
our study that slower rates of cocaine infusion might lead to similar or greater escalation 
in intake. However, I do not know if slow rates of cocaine delivery could induce greater 
withdrawal symptoms in rats as the impact of varying rates of cocaine infusion on ICSS 
threshold is not known. This question would merit further study. 
The hedonic allostasis hypothesis proposes that the mechanism underlying relapse 
in humans is a persistent state of withdrawal (Koob and Le Moal, 2001), reflected in long 
term tolerance in the mesocorticolimbic system to the effects of cocaine. Behaviorally, 
the hedonic allostasis hypothesis would suggest that rats given extended access to 5 sec 
infusions of cocaine would develop a dysregulated reward system resulting in a state of 
persistent withdrawal and a tolerance towards the rewarding effects of cocaine. Thus 
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given a priming injection, rats with a history of rapid infusion rates would experience 
greater anhedonia, and attempt to alleviate those symptoms by seeking drug even when 
not available. On the other hand, if longer rates of cocaine infusions were more effective 
in inducing withdrawal states (similar to methadone and heroin), one might expect the 
propensity to reinstate reversed. However, it seems unlikely that an increased state of 
withdrawal accounts for drug primed reinstatement behavior. While both rats and 
primates can robustly reinstate their cocaine seeking behavior after a priming injection of 
cocaine (Gerber and Stretch, 1975; de Wit and Stewart, 1981), inducing withdrawal in 
rats through the administration of antagonists does not reinstate their drug seeking 
behavior (Shaham and Stewart, 1995; Shaham et al., 1996).  
According to Ben-Shahar and colleagues (2004), one of the neurobiological 
manifestations of this heightened anhedonia after extended access self-administration is a 
persistent suppression of Fos expression. They demonstrated that in rats experienced with 
long access self-administration of cocaine, Fos immunoreactivity in the core and shell 
divisions of the nucleus accumbens was suppressed in comparison to animals with only 
limited access experience to cocaine self-administration after a 14 day period of forced 
withdrawal. Based on the importance of D1 dopamine transmission in facilitating Fos 
expression during an acute injection of cocaine, this loss of Fos expression was 
interpreted as a tolerance of D1 receptor dopamine neurotransmission.  
While there are experimental differences between the studies in this dissertation 
and with those of Ben-Shahar and colleagues (2004), I also found an enduring 
suppression of Fos expression in rats with a history of rapid rates of cocaine infusion 
compared to those with a history of extended access to slower rates of infusion during 
self-administration. While I agree that persistent Fos expression is an indicator for 
enduring neurobiological adaptations, evidence suggesting that this suppression is due to 
D1 receptor mediated tolerance is not clear. Desensitization of Fos expression in response 
to a cocaine challenge as a consequence of chronic treatment has previously been 
reported (Hope et al., 1992; Couceyro et al., 1994; Daunais and McGinty, 1994; Daunais 
et al., 1995; Moratalla et al., 1996; Willuhn et al., 2003; Zahm et al., 2009). In contrast, it 
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has also been reported that prior cocaine experience can enhance Fos expression in the 
nucleus accumbens produced by a drug challenge, although this was only seen after a 
long period of drug abstinence (Crombag et al., 2002; Todtenkopf et al., 2002) and only 
if cocaine was administered in association with environmental novelty (Hope et al., 
2006). However, this hypersensitivity is not always seen (e.g. Ostranader et al., 2003; 
Willuhn et al., 2003), and it is not clear exactly what conditions lead to a sensitization vs. 
desensitization of the Fos response, even following extended abstinence.  
It is also important to note that beyond the nucleus accumbens, the pattern of Fos 
expression varies widely in other corticothalamic systems in the brain (Zahm, 2006). Fos 
expression or suppression in these regions can be influenced by many experimental 
factors, including the specific area of the brain, whether cocaine was administered 
contingently through self-administration or by the experimenter, the amount of 
experience the animal had with respect to drug self-administration, and finally the degree 
to which the animal was experienced with the operant task and task environment without 
any drug experience (i.e. groups experienced only in saline self-administration) (Ben-
Shahar et al., 2004; Zahm et al., 2009). While a summary of the impact of all of the 
experimental manipulations in all 43 regions surveyed by Zahm and colleagues (2009) is 
beyond the scope of the current discussion, there are several key points from this study 
that have relevance to this dissertation. First, consistent with many other studies and with 
my own results, acute cocaine experience (1 day of self-administration) induces greater 
Fos expression than chronic cocaine experience in specific subregions of the dorsal and 
ventral striatum. Thus in my study, the persistence of accumbal Fos suppression only in 
rats with a history of rapid rates of delivery during extended access self-administration 
suggests two things. First, varying the rate of drug delivery during extended access self 
administration introduces a complex temporal dynamic in Fos suppression or expression. 
My results along with data from other experiments (Crombag et al., 2002; Todtenkopf et 
al., 2002) suggests that striatal Fos expression undergoes a biphasic time course 
consisting of an initial suppression, then a return to initial levels of inducibility, and 
followed by a period of hyperinducibility. Although it is clear from my results that at 45 
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days after their last self-administration session, animals with a history of 5 sec drug 
delivery had a persistent suppression in the ability of cocaine to induce Fos expression in 
comparison to animals with a history of 45 and 90 sec drug delivery, it remains to tested 
whether 5 sec animals evince hyperinducibility at an even later timepoint.  Secondly, my 
results leave open the possibility that Fos inducibility in other regions of the brain is also 
impacted by varying the rate of drug delivery during chronic extended access experience. 
Many other brain regions such other parts of the mesocorticolimbic system and those 
involved in other brain circuits such as the extended amygdala show altered Fos 
inducibility (Ben-Shahar et al., 2004; Zahm et al., 2009).  For example, although not 
surveyed in my extended access experiment, it is reasonable to predict that faster rates of 
drug delivery during extended access self-administration will lead to preferential 
expression of Fos in striatal neurons in the patch subcompartment, either by an enduring 
suppression of the inducibility of Fos in the matrix compartment, or by increased 
hyperinducibility in the patch compartment.   
One possible mechanism of suppressed Fos expression in the NAc after extended 
access experience might be that Fos expression is suppressed by the increased expression 
of ∆FosB. ∆FosB is a modified 35-37 kD Fos transcription factor from the fosB gene that 
has homology with c-fos (Morgan and Curran, 1991) and can also form functional AP-1 
subunits, influencing the transcription of downstream targets (Chen et al., 1997; Hiroi et 
al., 1998). In contrast to c-fos, ∆FosB has a long half-life (Chen et al., 1997; Nestler, 
2008) and accumulates in the nucleus accumbens as a result of repeated exposure drugs 
such as cocaine. The increased expression of ∆FosB in neurons as a result of repeated 
cocaine exposure has recently been shown to suppress Fos expression by a histone 
deacetylase 1 (HDAC1) chromatin remodeling mechanism (Renthal et al., 2008). These 
studies strongly support the hypothesis that suppression of Fos activation due to extended 
access to fast rates of cocaine infusion is a result of many long-term neuroadaptations 
related to psychomotor sensitization and do not necessarily imply either a tolerance of the 




Although some have proposed that changes in Fos activation and suppression can 
be correlated with changes in neurophysiological activity and therefore also with 
behavior (e.g. Zahm et al., 2009), such inferences on the basis of Fos expression are 
fraught with complications. First and foremost, Fos can be both a marker for intracellular 
biochemical activation in response to a stimulus and a transcription factor initiating long 
term neuroadaptations.  Thus once a stimulus such as drug administration is repeated, it 
immediately becomes difficult to distinguish Fos expression from its distinct two roles.  
Secondly, while the spatial sensitivity of Fos activation is high, the temporal resolution of 
Fos activation is extremely low (Kovacs, 2008), thus making strong correlations with 
specific operant behaviors becomes extremely problematic. In order to address further 
questions relating the activity of specific neurons in relationship to behavior, it is critical 
to use other methods of observation with a much higher temporal resolution, such as 
awake-behaving electrophysiology, in vivo voltammetry, or microdialysis coupled to 
capillary electrophoresis with laser-induced florescence detection. 
Conclusions 
I have shown through the studies in this dissertation that faster rates of cocaine 
infusion have a greater neurobiological impact on parts of the brain associated with drug 
addiction. These faster rates also facilitate the development of drug-taking behaviors that 
resemble those seen in human addicts. Experiencing faster rates of drug infusion during 
this experience leads to a persistent vulnerability to relapse, and a heightened desire for 
drug after prolonged abstinence. I have also shown that the behavioral effects associated 
with fast rates of cocaine delivery also facilitate persistent neuroadaptations in brain areas 
associated with addiction. This may be one reason why routes of administration that 
result in the rapid entry of cocaine into the brain preferentially promote the transition 
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